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Few have utilised a randomised controlled study design to monitor cardiovascular health 
in adults who replace automotive forms of transport with cycling 1,2. Previous commuter 
cycling (CC) interventions observed enhanced cardiorespiratory fitness, mixed effects on 
body composition, whereas markers of insulin resistance have not been investigated. 
Furthermore, studies to date have omitted measures of physical activity (PA) and energy 
expenditure (EE) prior to initiating a routine of CC and therefore the contribution of the 
novel commuter cycling on existing PA and EE is unknown. The purpose of this study was 
to examine effects of CC on existing PA and EE, body composition and parameters of 
cardiovascular and metabolic health. Methods: Males and females who commuted by 
motorised transport were recruited and completed a graded exercise test on a cycle 
ergometer to determine V̇O2max, completed weighed food records, PA log books, and a 
validated PA questionnaire. Group assignment was randomised and matched for sex and 
fitness. The cycling group (CYC) (n=14, age 39±7 yr, body mass 77±11 kg, V̇O2max 2.8±0.8 
l•min-1) were given bicycles and asked to cycle commute for 100+ min/wk for 10 weeks. 
The control group (CON) (n=14, age 34±8 yr, body mass 70±7 kg, V̇O2max 2.6±0.7 l•min-1) 
continued using motorised transport. Baseline (wk0) testing included cholesterol fractions, 
triglycerides, C-reactive protein, fasting insulin and glucose (HOMA-IR) and body 
composition (mass, skin folds), blood pressure, resting heart rate and measures were 
repeated wk10. CYC also underwent pre and post-intervention dual-energy x-ray 
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absorptiometry (DXA) scans for assessment of body composition. Energy expenditure was 
estimated with energy intake data (wk0, wk4, wk8) with adjustment for energy balance 
from measures of fasted body mass at the same time points. Data were analysed using 
ANOVA for the group change from wk0 to wk10, and repeated measures ANOVA for data 
collected at 3 or more time points. Results: Analyses included 13 participants per group. 
CYC cycled 152 ± 60 min/wk, but did not alter (P>0.05) total levels of PA, energy intake 
or estimated EE. Consequently, no changes in body fat (P=0.69) or mass (P=0.61) were 
observed. V̇O2max (CYC: 10±17%, CON: -1.5±11%, P=0.03) and resting HR (CYC: -5±6%, 
CON: 3±9%, P=0.03) were improved, whereas diastolic BP increased in CON (CYC: -1±7%, 
CON 12±16%, P=0.02). There were no significant changes within or between groups for 
blood parameters. Conclusion: Commuter cycling for ~150 min/wk does not increase total 
PA and EE, which may be due to a reduction in non-cycling physical activities or the 
instruments used for PA and EE measures may have lacked resolution to capture change 
to short-lasting and spontaneous PA. Nevertheless, major markers for cardiovascular 
health were enhanced in just 10 weeks and the seasonal increase in diastolic BP observed 
in CON was prevented with CC in CYC. The lack of significant changes in blood 
parameters may be due to inadequate volume of exercise or duration of intervention. 
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CHAPTER ONE: Introduction 
Robust evidence supports the role of physical activity (PA) to reduce risk for developing 
various diseases, most notably those that affect metabolic and cardiovascular function 
(for review, see Haskell, et al., 2007). Participation in sport, recreation and active living 
are all practical means to accumulate public health recommendations for moderate 
intensity PA of 150+ min/wk (Haskell, et al., 2007). Active living may support 
integration of, and adherence to, PA into a daily routine better than group activities 
and facility-based programs (e.g. gyms) (Hillsdon, et al., 1995). Commuter cycling is an 
efficient and practical example of active living, as it assists with the incorporation of 
PA into the time of day that would otherwise be unproductive. Although walking is 
convenient for short distances, cycling can cover a greater distance per time and is 
performed at a physiological intensity that generally supports greater cardiovascular 
benefits than those from walking (Oja, et al., 1991). If performed by a large proportion 
of the population, commuter cycling may alleviate traffic congestion, air pollution, and 
some public health concerns such as those caused by physical inactivity (e.g. obesity).  
New Zealand rates third highest in the world for vehicle ownership in proportion to its 
population, with 607 vehicles per 1000 people (The Economist, 2008; Tin Tin, et al., 
2009). The high rate of vehicle ownership may increase the frequency of automotive 
trips, which may help to explain why two-thirds of all vehicle trips are six km or less, 
with half of those trips three km or less (Tin Tin, et al., 2009). To reduce the high rate 
of vehicle use, the Ministry of Transport aims to increase the total number of trips made 
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by active transport from less than 3% up to 30% by year 2040 (Ministry of Transport, 
2008; Tin Tin, et al., 2009). The optimistic active-transportation goals set by the 
Ministry of Transport will necessitate promotional strategies to encourage individuals 
to replace short vehicle trips with physically active modes of transport. Health 
promotion is sometimes utilised as a marketing tool to promote societal change, and 
health promotion campaigns were observed to increase participation in active 
transportation in Northern Europe (Vuori, et al., 1998; Oja & Vuori, 2000). However, 
the health benefits achieved from initiating a routine of commuter cycling are not well 
understood, which limits the use of health promotional strategies by government 
organisations to achieve their active transportation goals. 
Recreational cycling (i.e. sport or leisure-time cycling) is known to sufficiently strain 
metabolic and cardiovascular systems providing a protective effect against heart disease, 
stroke, high blood pressure, unfavorable blood lipid profiles, metabolic syndrome, some 
forms of cancers, improved cardiorespiratory and muscular fitness, reduced depression, 
and better cognitive function (for review, see Oja, et al., 2011). Commuter cycling 
differs considerable from recreational cycling and may not offer the same benefits to 
health. For example, the time of day that cyclists commute will generally coincide with 
peak traffic hours. Increased ventilation with exercise combined with increased car 
emissions at peak traffic times may have adverse health effects (Bigazzi & Figliozzi, 
2014). Peak traffic may also impose frequent periods of inactivity at intersections and 
the physiological intensity of cycling may be lower than that of recreational cycling 
due to social norms in the workplace regarding body sweat, odor and attire, particularly 
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if showering facilities are not present. Finally, cycling on the road increases the risk of 
injury and mortality compared to motorised transport (including public transport) and 
walking (Tin Tin, et al., 2010). Acquiring an injury can decrease quality of life and 
health (e.g. Moreira, et al., 2014). Although evidence of improved health with 
recreational cycling is robust, it is unclear if commuter cycling offers the same benefits.  
Few have examined the role of cycling in a transportation context for reduced risk of 
developing disease (Oja, et al., 1991; Hendriksen, et al., 2000; de Geus, et al., 2008; 
Møller, et al., 2011). Aforementioned authors all reported significant improvements to 
V̇O2max from commuter cycling. Improvements to other health parameters from 
commuter cycling are not well supported. For example, the findings of decreased body 
fatness (Møller, et al., 2011) and a lack of change in inflammation markers (de Geus, et 
al., 2008) come from one investigation each, with confirmation from other commuter 
cycling interventions lacking. Several studies have concluded that commuter cycling is 
ineffective in altering blood pressure (de Geus, et al., 2008; Møller, et al., 2011), blood 
cholesterol and triglycerides (Oja, et al., 1991; de Geus, et al., 2008), in 8, 10, and 52 
week trials. Although the aforementioned findings are supported in multiple studies, 
the varying length of commuter cycling studies and load of cycling performed weakens 
the evidence from the repetitive findings. Whether or not commuter cycling can 
enhance insulin and glucose dynamics has yet to be investigated in a peer-controlled 
intervention. Furthermore, previous commuter cycling interventions excluded pre-
intervention measures of physical activity and energy expenditure. Therefore, it is 
unknown if compensation in existing PA and EE occurred, which could reduce the 
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benefits from initiating a routine of cycle commuting. On the other hand, novel 
commuter cycling may have inspired PA beyond that accumulated from cycling. Thus, 
health gains could be attributed to the commuter cycling and other forms of PA 
combined.  
In summary, health promotion initiatives will require evidence of health gains with 
commuter cycling to promote participation in commuter cycling to improve social 
problems such as traffic congestion, air pollution, as well as possibly improve personal 
health. Controlled interventions monitoring the health gains of commuter cycling are 
few, and vary in design and quality, thus preventing generalisations about the health 
benefits of this form of cycling. Furthermore, it is unknown how initiating a routine of 
commuter cycling will impact total PA and EE and whether health responses obtained, 
or lack thereof, are related to these parameters. Therefore it was the purpose of this 
thesis research to investigate the effects of bicycle commuting at a self-selected 
intensity for 10 weeks on existing PA and EE, and on parameters of health. 
The objectives were to determine the extent to which incorporating bicycle commuting 
into the daily routine 1) increases overall physical activity and energy expenditure, 2) 
improves body composition, 3) enhances cardiovascular and metabolic health and 4) 
improves health related quality of life. The hypotheses were that commuter cycling 
will 1) increase total levels of physical activity, 2) increase cardiovascular fitness and 3) 




CHAPTER TWO: Literature Review 
2.1 Introduction 
Commuter cycling is a utilitarian activity that offers the convenience of accumulating 
physical activity into the time of day generally reserved for physically inactive 
transport to/from work, whilst potentially saving costs from fuel and parking, reducing 
carbon emissions compared to automotive transport and generally offers greater 
cardiovascular and metabolic strain than walking (Oja, et al., 2011; Oja, et al., 1991). 
However, when compared to recreational cycling, cycling for transport may be less 
intense, of shorter duration and have a higher potential for adverse health effects (e.g. 
air pollutants, traffic incidents) (Oja, et al., 2011). Although recreational cycling is well 
established to enhance cardiovascular health, commuter cycling has received 
considerably less attention in research literature and little is known about the health 
gains to be expected upon incorporating commuter cycling into a daily routine (Oja, et 
al., 2011). Large population studies utilising cross-sectional research methods report 
that commuter cyclists have favourable markers for cardiovascular health above those 
who use motorised transport (Hamer & Chida, 2008). However, randomised controlled 
trials on the protective effect from cardiovascular disease with commuter cycling are 
ambiguous. Current evidence on the role of commuter cycle on parameters of health 
(e.g. blood cholesterol and inflammation, blood pressure, glucose/insulin dynamics, 
abdominal body fat) are equivocal due to a lack of repetition in the research literature, 
or a complete absence of investigative evidence. Evidence is further hindered because 
the impact that novel commuter cycling has on participants’ physical activity (PA) and 
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energy expenditure (EE) is unknown. Without first understanding the impact of novel 
PA on existing activity and EE, the benefits of the PA cannot be ascertained.  
The forthcoming chapter will review known evidence on the health benefits gained 
from physically active transportation, with emphasis on commuter cycling where 
evidence is available. The mechanisms responsible for the reduced risk of 
cardiovascular disease through commuter cycling will be examined, as well as the 






2.2 Physical Activity 
Effects of commuter cycling on physical activity  
 
The effect of commuter cycling on total PA has not been investigated with an 
experimental research design. In a systematic review on the associations between 
physically active transport and total PA, 14 of the 15 included studies reported positive 
associations between physically active transport and increased total PA (Wanner, et al., 
2012). Five of the 16 studies reported associations between all PA variables; nine 
reported some association, one study observed no association between physically active 
transport and PA (Wanner, et al., 2012). However, most studies combined walking and 
cycling as modes of transport and are inclusive of all forms of transport, not just 
commuting to and from the workplace, which limits generalisations for the role of 
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commuter cycling. Four studies from the review also reported the relationship of 
cycling for transport on total PA (Table 2.1). Wanner et al. (2012) identified four studies 
that observed an association with cycling for transport and greater scores in some PA 
variables “(i.e. time engaged in PA and/or frequency of PA bouts per week) over non-
active transportation users (Boone-Heinonen, et al., 2009; Titze, et al., 2008; Gómez, et 
al., 2005; Wanner, et al., 2012). Wanner et al. (2012) developed a rating scale to define 
the quality of included studies, which was based on the objectivity of methods for PA 
and transport measures, validity of measurement tools, sample size, research design and 
control for other variables (e.g. age, gender, education, income). The aforementioned 
studies are presented in table 2.1, which averaged a rating of four on a one (lowest) to 
ten (highest) scale. The relatively low-quality score for the studies on the role of cycling 
for transport on increased total PA, in conjunction with no known data from 
experimental study designs warrants further investigation into the potential for 
commuter cycling to be utilised to increase total PA.   
Time spent commuter cycling 
Novel commuter cycling in previous longitudinal studies was generally performed 
below government-issued recommendations on the amount of moderate-intensity PA 
to enhance or maintain health (e.g. 150 min/wk moderate PA) (Oja, et al., 1991; 
Hendriksen, et al., 2000; de Geus, et al., 2008; de Geus, et al., 2009), with one exception 
(Møller, et al., 2011). Time engaged in commuter cycling by participants from Møller 
et al. (2011), was not measured directly; rather it was estimated from the distance 
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Table 2.2 Summary of studies on the association between cycling for transport on increased 
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category: 
OR mod = 0.82 (0.52, 1.30);  




















OR for CYC compared to 
car according to PA 
category: 
to recreational facility: 
OR high = 1.52 (0.82, 2.82); 
to park:  
OR high = 1.75 (1.24, 2.47);  
to grocery store:  
OR high = 1.35 (0.87, 2.11);  
to public transit:  
OR high = 0.96 (0.39, 2.36). 
Abbreviations: day (d), week (wk), cycling (CYC), physical activity (PA), leisure-time physical 
activity (LTPA), confidence intervals (CI), odds ratio (OR), moderately active (mod), regular 






Whether or not this increased PA levels beyond pre-intervention levels was not 
reported, but authors reported significantly improved body composition (i.e. skin fold 
thickness) after 8 weeks of commuter cycling, which indicates the load of PA from 
cycling likely increased total PA levels (Møller, et al., 2011). Improved body 
composition wasn’t observed in any other commuter cycling study (detailed in 
subsequent section), but in those studies, participants cycled less than the public 
recommendations for PA. In another commuter cycling intervention, participants 
cycled less than 150 min/wk, but exceeded the amount of time recommended for 
weekly PA through combined commuter cycling and leisure-time PA (de Geus, et al., 
2008, 2009). However, the impact that commuter cycling had to existing PA is 
unknown, as de Geus et al. (2008, 2009) didn’t report pre-intervention levels of PA. In 
summary, only one study contained participants that cycled for transport above public 
recommendations for PA and another study observed participants to meet PA 
guidelines through combined cycling and existing PA habits. It is unknown however, 
if commuter cycling enhances existing levels of PA. 
 
Time spent commuter cycling 
Novel commuter cycling in previous longitudinal studies was generally performed 
below public recommendations on the amount of moderate-intensity PA to enhance or 
maintain health (e.g. 150 min/wk moderate PA) (Oja, et al., 1991; Hendriksen, et al., 
2000; de Geus, et al., 2008; de Geus, et al., 2009), with one exception (Møller, et al., 
2011). Time engaged in commuter cycling by participants from Møller et al. (2011), was 
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not measured directly; rather it was estimated from the distance participants cycled. 
An estimate of 200 min/wk of commuter cycling was performed by participants. 
Whether or not this increased PA levels beyond pre-intervention levels was not 
reported, but authors reported significantly improved body composition (i.e. skin fold 
thickness) after 8 weeks of commuter cycling, which indicates the load of PA from 
cycling likely increased total PA levels (Møller, et al., 2011). Improved body 
composition wasn’t observed in any other commuter cycling study (detailed in 
subsequent section), but in those studies, participants cycled less than the public 
recommendations for PA. In another commuter cycling intervention, participants 
cycled less than 150 min/wk, but exceeded the amount of time recommended for 
weekly PA through combined commuter cycling and leisure-time PA (de Geus, et al., 
2008, 2009). However, the impact that commuter cycling had to existing PA is 
unknown, as de Geus et al. (2008, 2009) didn’t report pre-intervention levels of PA. In 
summary, only one study contained participants that cycled for transport above public 
recommendations for PA and another study observed participants to meet PA 
guidelines through combined cycling and existing PA habits. It is unknown however, 
if commuter cycling enhances existing levels of PA. 
 
Physiological intensity of commuter cycling 
Although measures of the duration of cycling and existing PA in previous studies lacked 
objectivity, measurements of the physiological intensity of commuter cycling was 
performed with highly standardised measurement procedures in several studies (Oja, 
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et al., 1991; Hendriksen, et al., 2000; de Geus, et al., 2007, 2008, 2009). In general, 
commuter cycling is performed at 60-65% of participants’ V̇O2max (Oja, et al., 1991; 
Hendriksen, et al., 2000; de Geus, et al., 2008). However, one group of participants 
cycled at 75% V̇O2max when performing a field test along their typical commuting 
route (de Geus, et al., 2007). Intensity of the field test was measured with a portable, 
indirect calorimetry system. Although the indirect calorimetry is a gold standard 
method for measuring respiratory function from a free-living activity, participants rode 
significantly faster during the field test than their normal commute and therefore the 
measure of intensity is an over estimate of those participants’ normal commute (de 
Geus, et al., 2007). Data indicates commuter cycling is generally performed at 
moderate-intensity, which provides enough cardiovascular strain to promote 
adaptations that are known to reduce risk for developing disease (Haskell, et al., 2007; 
Lee, et al., 1995). This evidence hints at the prospect of commuter cycling being a viable 
means to increase health, however, the duration people are willing to engage in 
commuter cycling per week, as well as the effects it may or may not have on total level 
of PA is still unknown and requires investigation to determine if commuter cycling can 
be promoted as a health enhancing activity.  
 
Compensation of Energy Expenditure and Physical Activity 
Initiating novel PA into the daily routine may or may not result in increased levels of 
EE or PA. Individuals may respond to novel PA by reducing non-exercise activities 
(Goran & Poehlman, 1992). Non-exercise activities include spontaneous movements 
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associated with posture, daily living and fidgeting (Goran & Poehlman, 1992). Both 
biological and behavioural mechanisms may explain the compensation of activity and 
EE (Garland, et al., 2010). For example, biological sources for compensation may be 
attributed to sympathetic response to restore energy balance after PA (Meijer, et al., 
1991). Alternatively, individuals may knowingly restore energy balance by physically 
resting or by increasing caloric intake (King, et al., 2006). However, any account on the 
mechanisms that drive energy compensation should be approached with caution as 
underlying mechanisms are not well understood and involve hormones, circulating and 
stored substrates, feedback from peripheral tissues and substrate utilisation to higher 
centres (for review, see Garland, et al., 2010).  
 
Compensation from non-exercise activity 
Studies that have monitored the effects of exercise on the energy expended from non-
exercise activities are surprisingly sparse and even fewer studies exist on the detriment, 
or lack thereof, that EE compensation has on health-related outcome variables. For 
example, compensation of EE (Goran & Poehlman, 1992) and PA (Meijer, et al., 1999) 
has been observed with elderly participants who have partaken in an exercise training 
program. Goran and Poehlman (1992) observed a return to pre-intervention levels of 
EE during the last 10 days of the eight week exercise program, utilising the doubly 
labelled water (DLW) technique. Similarly, Meijer, et al., (1999) observed a significant 
decrease of non-exercise activities on training days during the 12th and final week of 
their exercise training intervention. Nevertheless, training programs from both studies 
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improved V̇O2max among the elderly participants, even though compensation of PA 
and EE was observed (Goran & Poehlman, 1992; Meijer, et al., 1999).  
In support of the aforementioned studies, Colley et al. (2010) reported compensation of 
EE among obese women initiating a walking intervention. The walking intervention 
increased participant EE between ~4200-6300 kJ/wk. However, total EE remained 
unchanged from pre-intervention measures, assessed by DLW method (Colley, et al., 
2010). Colley et al. (2010) suggested that the lack of change in total EE during the 
intervention was due to compensation from non-exercise activities, an increase in sleep 
time and reduction in light-intensity PA. Authors also commented that it is unknown 
if the reduction in light activities resulted from decreased frequency and/or duration of 
light PA, or if light activities were increased into moderate-intensity activities (Colley, 
et al., 2010). 
Research on elderly participants (Goran & Poehlman, 1992; Meijer, et al., 1999) and 
obese women (Colley, et al., 2010) indicates that novel PA may decrease EE spent 
during non-exercise and light-intensity activities. In support of this, a meta-analytic 
review reported that within-individual variation of daily EE is 8% and increases to 10% 
after three months of training and variation may rise to 15% with long-term training 
(Black & Cole, 2010). Surprisingly, similar observations of EE compensation have been 
observed among young adults (Wickel & Eisenmann, 2006). Using the DLW technique, 
Wickel and Eisenmann (2006) observed EE from light-intensity activities to change 
inversely with the amount of moderate and vigorous PA performed by participants. 
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Few have reported evidence for compensation with novel PA, nevertheless it has been 
observed in elderly, young adults and obese women. Despite the presence of 
compensation, participants’ V̇O2max was significantly improved. How other markers of 
health (plasma cholesterol, fasting glucose, blood pressure, adiposity, etc.) respond to 
exercise training when compensation occurs is not clear.  
 
Summary  
Commuter cycling is generally performed at moderate-intensity, which favours 
improved long-term health and fitness. On the other hand, the duration of commuter 
cycling is often performed below government-issued recommendations for weekly PA. 
Although participants may have meet PA recommendations with combined commuter 
cycling and leisure-time PA, the duration of leisure-time PA is only measured from one 
sample of participants (de Geus, et al., 2008, 2009). Furthermore, no existing research 
has monitored the effects of initiating a routine of commuter cycling on existing PA 
levels. Some cross-sectional evidence indicates that those who cycle for transport may 
have greater total PA compared to motorised transport users, however the quality of 
evidence is reportedly low (Wanner, et al., 2012). Previous authors utilising controlled 
trials did not report the effects of commuter cycling on existing PA, and in general, the 
effects of novel exercise on EE and PA in adults is seldom investigated. Research 
investigating the impact of novel PA on health outcomes need to monitor existing PA 
and EE to validate the load of PA has on total EE and the consequent changes to health 
(if any) from that load. 
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2.3 Body composition 
Unhealthy waist to hip ratio (WHR) (> 0.95 for men, > 0.80 for women) is associated 
with increased risk for several ailments including cardiovascular disease, diabetes, and 
some forms of cancer (eg. Plodkowski & St. Jeor, 2003; Pitsavos, et al., 2007). A 
multitude of cross sectional and prospective cohort studies have resulted in mixed 
findings for associations between PA levels and body mass (eg. Williamson, et al., 1993; 
Schoeller, et al., 1997; Di Pietro, et al., 2004). Similar to the large population studies, 
intervention trials have also resulted in mixed results for the role of PA on body 
composition. (eg. Møller, et al., 2011; Lehmann, et al., 1997; Rice, et al., 1999; 
Yamamoto, et al., 2007). The discrepancy in results between studies may be due to 
compensation of reduced EE and/or increased energy intake with exercise training. For 
example, caloric intake has been observed to increase with physical activity (eg. 
Donnelly & Smith, 2005; King, et al., 2007). Thus, compensatory behaviour will 
diminish exercise-induced reductions in energy balance and consequent loss of body 
fatness and mass. Furthermore, without the use of advanced research instruments such 
as Dual-energy X-ray absorptiometry (DXA), gains in muscle mass may not be detected, 
adding further ambiguity to previous research.  
 
Body composition among active transport users 
It is unclear if physically-active transportation produces enough strain among users to 
reduce long-term energy balance or affect skeletal muscle mass. Interestingly, some 
evidence indicates that BMI is lower among those who use physically active transport 
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(Hayashi, et al., 1999; Wagner, et al., 2001; Hu, et al., 2002; Gordon-Larsen, et al., 2009). 
It is important to note however, that BMI does not directly measure body fatness or 
composition, but may allow for generalisations of body composition (Lee, et al., 1999). 
A prospective study by Gordon-Larsen et al. (2009) reported lower BMI in male 
participants that used active forms of transportation for an average of 20 mins/day, but 
not females, after a twenty-year follow-up. Authors commented that females 
performed significantly less (15%) active transport than males, which may explain the 
gender differences they observed (Gordon-Larsen, et al., 2009). Whereas, others also 
observed lower BMI among active transport users, in both genders (Hayashi, et al., 
1999; Wagner, et al., 2001; Hu, et al., 2002). Although there isn’t complete concensus 
in the research literature on the role of  habitual use of active transport and it’s effect 
on BMI, there is evidence to suggest it may be a useful mode of PA to enhance body 
composition, but the use of objective measures for body composition (i.e. WHR and 
DXA) are required.  
In research specific to commuter cyclists, evidence for enhanced body composition is 
equivocal.  Møller, et al., (2011) observed reduced skin fold thickness in cyclists after 
eight weeks of commuter cycling. Contextualising the results to other studies is 
hampered because the volume of CC performed was not measured. In a longer 
controlled trial, body mass and BMI were unchanged at the 26 week follow-up, and 
interestingly, de Geus et al. (2008) observed an increase over time in body mass among 
cyclists and a decrease in body mass in controls between weeks 26 and 52. Authors 
reported a decrease in the amount of time spent cycling between weeks 26 and 52, 
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which may explain the increase in body mass with cycling, but rationale for 
improvements among controls was not speculated on (de Geus, et al., 2008). 
In summary, cross-sectional and longitudinal investigations have observed lower BMI 
among users of physically-active modes of transport when compared to those who use 
automotive transport; however, BMI is not a direct measure of body composition. Two 
controlled trials aimed to understand the role of CC on body composition and mass, 
where one reported an unexpected finding of increased body mass, and the other 
observed reduced body fatness, but the volume of cycling to achieve the result was 
unreported. Further confounding the evidence is the amount EE required from PA to 
improve body composition varies per individual due compensatory behaviours that 
result in increased caloric intake (e.g. Colley, et al., 2010) or decreased EE from other 
activities (Wickel & Eisenmann, 2006). Further research may enhance our 
understanding on the energy requirements of commuter cycling, the occurrence and 
degree of compensation in EE from other physical activities, and the effects commuter 
cycling has on muscle and fat mass by use of objective research tools (i.e. DXA).    
 
 
2.4 Cardiovascular Diseases 
Cardiovascular diseases (CVD) is a collection of diseases affecting cardiac muscle and 
blood vessels. The disease progresses with age, generally due to a habitually unhealthy 
lifestyle and the most serious acute events are myocardial infarction and stroke, caused 
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by atherosclerosis (Squires, 2005). Atherosclerosis is caused by chronic inflammation 
in the arteries because of dyslipidaemia, hypertension and other modifiable risk factors 
(e.g. Ross, 1986; Nabel & Braunwald, 2012). Prolonged presence of risk factors increases 
exposure of endothelial cells to oxidative, inflammatory, and biochemical stimuli (eg. 
Furchgott & Zawadzki, 1980; Nabel & Braunwald, 2012). Through chronic exposure to 
CVD risk factors, endothelial cells change in permeability to allow entry of LDL 
cholesterol particles eventuating into lesions of plaque in the artery wall that obstructs 
blood flow in the artery (Furchgott & Zawadzki, 1980). When atherosclerosis results in 
occlusion of blood flow, nutrient and oxygen supply to the heart, brain or lower limbs 
can be compromised and result in a cardiovascular event (Squires, 2005).  
For research groups, atherosclerosis is invasive and expensive to measure directly, 
therefore researchers often study the risks of developing atherosclerosis and CVD. Risk 
factors include unfavourable blood concentrations of low-density and high-density 
lipoprotein (LDL and HDL) cholesterol, high concentrations of triglycerides, C-reactive 
protein, fasting glucose and insulin, high blood pressure, smoking, significant 
distribution of adipose tissue around the abdomen, physical inactivity, among others 
(Kannel & Larson, 1993; Kannel, 1990; Gordon, et al., 2005). Of interest to this thesis 
research is how PA is either inversely correlated to the risk factors specified above, or 




Epidemiological findings on the positive effects of exercise are also supported by data 
from robust experimental research trials (Braith & Stewart, 2006; Donnelly, et al., 2000; 
Jakicic, et al., 1999). However, exercise in previous research is generally supervised for 
intensity and adherence. Thus, the effects of exercise at a self-selected duration and 
intensity on CVD risk are less clear due to limited research that utilises free-living 
activities, opposed to laboratory-based exercise programs (Gray, et al., 2009). Exercise 
interventions in a free-living population have challenges with compliance and the 
volume of exercise performed is difficult to quantify. Commuter cycling is an example 
of a free-living PA where exercise duration is influenced by distance between 
participants’ home and place of work, and intensity is self-selected and potentially 
influenced by motivation, traffic and weather conditions. Commuter cycling trials to 
date have seen improved fitness with cycling, but other, more robust predictors for 
CVD have not been observed. On the other hand, longitudinal research has reported 
less frequent incidences of CVD events and reduced risk for developing CVD among 
those people who habitually use physically-active modes of transportation (Hamer & 
Chida, 2008; Wang, et al., 2010). Although physically-active transportation appears to 
offer a protective effect against CVD, the research isn’t specific to commuter cycling, 
and longitudinal studies generally utilise research methods that are less adept than 
randomised controlled trials for establishing a cause and effect relationship due to 
unknown influences from covariates. To date, evidence for the role of commuter 




2.5 Blood Pressure 
High blood pressure (BP) is robustly correlated to risk of cardiovascular disease and 
every increase of 20/10mmHg of systolic/diastolic BP over 115/75mmHg doubles CVD 
risk (Chobanian, et al., 2003). Long-term high systolic blood pressure increases risk of 
CVD through damage to the inner arterial walls, which increases susceptibility to the 
entry of cholesterol and inflammation factors, resulting in the hardening of arteries (i.e. 
atherosclerosis) (Alexander, 1995; Chae, et al., 2001). In addition to the protective 
effects of exercise on atherosclerosis, as previously discussed, several have reported PA 
as an effective method to reduce blood pressure (BP) among normotensive and 
hypertensive individuals (e.g. Arroll & Beaglehole, 1992; Kelley & McClellan, 1994; 
Kelley & Tran, 1995; Halbert, et al., 1997). Favourable changes in BP from PA result 
from reduced systemic vascular resistance due to involvement of the sympathetic 
nervous system and renin-angiotensin system (Fagard, 2006; Guyenet, 2006). Reduced 
sympathetic tone lowers activity of arterial smooth muscle causing vasodilation of 
arterial endothelium and therefore reduced vascular resistance (Guyenet, 2006; Young, 
2010). The reduction in vascular resistance is the primary mechanism for decreased 
arterial blood pressure at rest with regular exercise (DeSouza, et al., 2000; Tashiro, et 
al., 1993). Mechanisms for reduced BP appear responsive to both low and high-
intensity PA (Roman, et al., 1981; Matsusaki, et al., 1992; Tashiro, et al., 1993; Rogers, 
et al., 1996). However, controlled commuter cycling studies have not observed lower 
BP among cyclists compared to control participants. 
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The effects of commuter cycling on BP have been investigated with an eight week 
controlled trial (Møller, et al., 2011) and a 52 week non-randomised trial (de Geus, et 
al., 2008). Diastolic BP was lower by ~4.6 mmHg after eight and 52 weeks of commuter 
cycling, but no changes were observed compared to controls (de Geus, et al., 2008; 
Møller, et al., 2011). In contrast to de Geus et al. (2008), Møller et al. (2011) also 
observed a decrease in systolic BP over time amongst cyclists, but again no group effect 
was present. Interestingly, Møller et al. (2011) reported lower BP among controls 
during the same intervention period and therefore it is unclear if changes over time 
with the cycling group were a result of the cycling or other factors (e.g. seasonal) that 
also affected the control group.  
The lack of differences between cycling and control groups contradicts robust evidence 
for the role of PA on BP. Diastolic blood pressure appears most responsive to change 
with regular commuter cycling, but findings should be interpreted cautiously due to 
the lack of change between experimental groups. However, the reduction seen over 
time is an interesting finding that deserves further investigation.   
 
2.6 Resting Heart Rate  
Decreased resting heart rate (HR) is a reliable, non-invasive indicator for reduced risk 
for a cardiac event (i.e. sudden cardiac death, myocardial infarction), which has 
prognostic value of CVD risk independent of other risks factors (Smith, et al., 1989; 
Kannel, et al., 1987). Although the effects of PA on resting HR haven’t been 
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investigated in the context of physically active transport, robust evidence supports 
aerobic endurance training to reduce resting HR (Barnard, 1975; Scheuer & Tipton, 
1977; Moore & Korzick, 1995). For example, interventions with aerobic exercise have 
resulted in significant reductions in HR of 3 BPM after 20 weeks (Wilmore, et al., 1996), 
10 BPM (Byrd, et al., 1974) and 11 BPM (Edwards, 1974) after 12 weeks and 11 BPM 
in 10 weeks (Macial, et al., 1985). Endurance training in those studies was likely to 
expand plasma volume resulting in increased stroke volume of the heart, thus requiring 
less heart beats to maintain resting cardiac output (Convertino, et al., 1991). 
Furthermore, exercise training increases parasympathetic autonomic control and 
decreases sympathetic autonomic control (Smith, et al., 1989; Wilmore, et al., 1996). 
Finer control of the autonomic nervous system decreases secretion of epinephrine and 
norepinephrine from the adrenal medulla, which in turn reduces heart rate (Young, et 
al., 2010). Resting HR is therefore an indicator of resting cardiac output as it relates to 
vascular resistance and stroke volume of the heart and a training effect is possible with 
regular aerobic exercise. There is however no known evidence that commuter cycling 
is generally performed at an intensity and frequency reduce resting HR.  
More research should utilise resting HR as an outcome measure to enhanced knowledge 
of its effects with various types of exercise modalities and loads. With modest 
equipment and training, resting HR can be measured by the general public, 
empowering people to gain feedback on improvements to resting HR with exercise 




2.7 Aerobic capacity 
 
Low cardiorespiratory fitness is defined by V̇O2max of 25 ml/kg/min for people under 
30 years of age and 16 ml/kg/min for people over 60 years of age (McArdle, et al., 2001). 
Low fitness is a well-established risk factor for all-cause mortality, particularly death 
from cardiovascular events (e.g. Paffenbarger, et al., 1986; Williams, 2001). Improved 
fitness can independently counteract the life-shortening effects of smoking, unhealthy 
body mass, genetic predisposition to early mortality and increase longevity in healthy 
adults (Paffenbarger, et al., 1986; Lee, et al., 1995). Further, fitness is a predictor of CVD 
risk of equal magnitude to other major risk factors such as smoking, unfavourable 
cholesterol and blood pressure (Powell, et al., 1987).  
Cycling for recreation, sport and commuting consistently improves cardiovascular 
fitness (Oja, et al., 2011). Commuter cycling studies to date have resulted in improved 
V̇O2max compared to control participants (Table 2.2). However, the role of commuter 
cycling to improve V̇O2max within the cycling groups (i.e. within group change) is less 
clear (Table 2.2). The absence of within-group change for V̇O2max with commuter 
cycling may be due to seasonal changes in fitness when testing was performed after 
winter (de Geus, et al., 2008), gender differences as a result one gender group had no 
change and may have precluded total group change (Hendriksen, et al., 2000), or no 
within-group statistics reported (Oja, et al., 1991). 
Robust evidence supports commuter cycling as beneficial for improved cardiovascular 
fitness above controls. However, future controlled trials with commuter cycling should 
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include V̇O2max as an outcome measure to compare the effect (i.e. magnitude of 
change) in fitness as a basis to compare the effects for other outcome measures.   
 
 
Table 2.7: Summary of studies on the improvements to ?̇?O2max with commuter cycling. 







2.8 Blood Cholesterol and Triglycerides 
Unfavourable levels of plasma cholesterol and triglycerides are well established to 
increase risk of morbidity from heart disease (Rhoads, et al., 1976; Fuster, et al., 1996). 
Specifically, high concentrations of LDL cholesterol and triglycerides are correlated 
with increased risk of a coronary event, whereas high concentrations of HDL 
cholesterol are inversely correlated to risk of a coronary event (e.g. Rhoads, et al., 1976; 
Gordon, et al., 1977). Protective effects of exercise on cholesterol and triglyceride levels 
Author / location Study design Sample size Results 










CON group: n=33 
Cyclists higher (P = 0.01) than walkers. 
ACTIVE group higher (P = 0.02) than 
CON group. 









CYC group: n=57 
CON group: n=58 
CYC group higher (P < 0.01) than 
controls. Group change over time not 
reported, CYC group males increased (P 
< 0.01) over time, but not females. 






trial; 26 and 52 
wk follow-up. 
CYC group: n=72 
CON group: n=15 
CYC group higher (P < 0.01) than 
controls at wk 52. 
N.C. over time. 





8 wk follow-up. 
CYC group: n=25 
CON group: n=23 
CYC group higher (P < 0.01) than CON 
group and increased over time (P < 0.01). 
CON group increased (P < 0.01) over 
time.   
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are well established (e.g. Lloyd-Jones, et al., 2004; Mann, et al., 2014). The volume of 
PA to reverse unfavourable cholesterol and triglycerides depends on the duration and 
intensity of exercise, and existing levels of cholesterol and exercise habits (Mann, et al., 
2014).  
Short interventions (i.e. 12 +/- weeks) have produced mixed findings on changes to 
cholesterol and triglyceride levels (El-Sayed, 1996; Spate-Douglas & Keyser, 1999; 
Houmard, et al., 2004). Nevertheless, a review paper that included results from 13 meta-
analyses reported that cholesterol and triglycerides can change favourably through 
habitual physical activity (Pedersen & Saltin, 2006). High-intensity PA is generally 
more effective to improve blood levels of cholesterol and triglycerides than lower 
intensity activities (Tambalis, et al., 2009). It could be that higher intensity aerobic PA 
increases energy expenditure and therefore skeletal muscles utilise a greater amount of 
lipids (Mann, et al., 2014).  Compensation in EE with novel PA may not increase the 
amount of plasma lipids utilised by skeletal muscle and therefore cholesterol and 
triglycerides may remain unchanged. Change to LDL cholesterol with exercise may also 
improve through increased high-density lipoprotein (HDL) cholesterol (Shaw, et al., 
2009; Mann, et al., 2014). The increase of HDL and associated enzymes (i.e. lecithin-
cholesterol acyltrans and ester transfer protein) assists with removal of cholesterol from 
the blood and prevents HDL from being converted to other lipoproteins (Mann, et al., 
2014). Data on the effects of PA on cholesterol in free-living individuals, whilst 
controlling for existing PA and EE habits is obscure and further research would 
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enhance knowledge on the practicality of using exercise to prevent and reduce high 
cholesterol in minimally supervised exercise programs.  
 
Effects of physically active transport on cholesterol and triglycerides 
Two cross-sectional studies measured the role of physically active transport on levels 
of blood cholesterol (Hu, et al., 2001; Gordon-Larsen, et al., 2009). Hu et al. (2001) 
observed favourable changes in triglycerides, HDL and LDL cholesterol among 
participants who actively commuted. Authors reported improvements to cholesterol 
were independent of leisure-time PA in their linear regression analysis, but the 
duration and intensity of leisure-time PA and active transportation were not reported 
(Hu, et al., 2001). Results published by Gordon-Larsen et al. (2009) were less supportive, 
and reported lower triglyceride levels among male participants, but not females 
(Gordon-Larsen, et al., 2009).  Male participants were more physically active than 
females during the research period and were likely to have influenced gender 
differences in the results (Gordon-Larsen, et al., 2009). Furthermore, after adjustment 
for BMI, smoking and alcohol consumption, all cholesterol measures lacked statistical 
significance (Gordon-Larsen, et al., 2009).  
Two intervention trials have measured blood cholesterol and triglyceride levels among 
commuter cyclists (Oja, et al., 1991; de Geus, et al., 2008). Oja et al. (1991) observed no 
change to triglycerides or LDL cholesterol, but a trend (i.e. P = 0.06) was observed for 
increased HDL cholesterol between physically active commuters and controls after 10 
weeks. Specific results for the effects of blood parameters from commuter cyclists were 
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not reported. On the other hand, de Geus et al. (2008) reported improved blood levels 
of total cholesterol, LDL cholesterol, HDL cholesterol, but not triglycerides after 26 
weeks of commuter cycling. However, improved blood parameters were only 
significant over time, not between the cyclists and the non-randomised control group. 
Repeat measures of cholesterol at week 52 did not indicate any further improvements 
from measures at week 26 (de Geus, et al., 2008). The lack of change between cycling 
and control groups may be due to unexpected and significant decrease in total and LDL 
cholesterol among controls during the intervention period (de Geus, et al., 2008). The 
study had methodological shortcomings including a non-randomised group selection, 
inclusion of office workers only, and post-intervention testing took place after a 
significant decline in PA and commuter cycling, potentially due to Northern European 
winter conditions.  
 
Summary 
Current evidence for improved blood cholesterol with physically active transport is 
limited by methodological inconsistencies in cross-sectional and controlled 
intervention trials. Cross-sectional research has resulted in mixed effects for improved 
blood parameters amongst physically active transport users. Discrepancies in the 
findings may have resulted from imprecise measures of PA, such as an unknown 
contribution of walking versus cycling for transport and unknown physiological 
intensity of participants’ PA. In the very few controlled commuter cycling studies to 
date, cholesterol has not been observed to change in cyclists compared to controls and 
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it is unclear if the physiological strain of commuter cycling is insufficient to cause 
change in cholesterol, or if the aforementioned short comings in previous research 
efforts has hampered the effects of the cycling intervention. Due to this scarcity of 
randomised controlled studies on the topic, further study is necessary for consensus on 
the role of commuter cycling for potential benefit in blood levels of cholesterol.  
 
 
2.9 C-reactive protein  
Although blood cholesterol levels are a well-established method for predicting CVD 
risk, some research indicates half the individuals who experience a cardiac event have 
normal lipid values (Ridker, et al., 2002). C-reactive protein (CRP) on the other hand, 
independently predicts risk of CVD and has demonstrated greater reliability than 
cholesterol alone for predicting CVD events (Ridker, et al., 1998; Ridker, et al., 2002). 
Combined cholesterol fractions with CRP in medical screening further enhances the 
predictive power for CVD (Ridker, et al., 2002).  
Infection and tissue damage result in an acute-phase, innate immune response, which 
increase some analytes (i.e. C-reactive protein (CRP), interlukin-6 (IL-6), fibrinogen) 
whilst others decrease (i.e. transferrin and iron) (Young, et al., 1991; Thompson, et al., 
1992; Gambino, 1997). Increases in analytes such as CRP are used as a clinical measure 
of an immune response to injury or infection. C-reactive protein is a reliable 
inflammation marker for clinical use due to the quick onset and high magnitude of its 
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release from the liver in response to tissue damage (Kushner, et al., 1978; Morley & 
Kushner, 1982). In addition to the liver, CRP is also produced in smooth muscle, such 
as the muscle in arterial walls in response to inflammation (for review, see Bassuk, et 
al., 2004; Plaisance & Grandjean, 2006). C-reactive protein is hypothesised to directly 
contribute to the formation of arterial lesions (Bassuk, et al., 2004). Specifically, chronic 
exposure to CRP may increase expression of endothelial surface adhesion molecules 
(Pasceri, et al., 2000), reduce nitric oxide bioavailability resulting in reduced 
vasodilation function (Venugopal, et al., 2002), increase LDL uptake by macrophages 
that accelerate formation of arterial lesions (Zwaka, et al., 2001), among other 
mechanisms (Bassuk, et al., 2004). Therefore, CRP is the leading biochemical marker 
for estimating CVD risk due to its direct and indirect role on arterial inflammation 
(Gordon, et al., 2005). 
 
The role of physical activity and weight loss on CRP 
Physical activity interventions that decrease body mass, waist circumference or 
percentage body fat often observe reduced CRP (Okita, et al., 2004; Martins, et al., 2010; 
Donges, et al., 2010). The mechanism for reduced CRP through improved body 
composition is supported by the hypothesis that IL-6 released from adipose tissue 
promotes the release of CRP (Bastard, et al., 1999). Therefore, reduced body fat will 
result in a lower circulating concentration of IL-6 and consequently less CRP.   
Okita et al. (2004) observed significantly lower body mass and CRP in participants after 
eight weeks of PA between 60 to 80% of maximal heart rate (HRmax). Similarly, Donges 
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et al. (2010) implemented an aerobic exercise intervention at 70% HRmax that resulted 
in reduced waist circumference compared to controls, reduced body fat within the 
exercise group and a trend (i.e. P = 0.06) towards reduced CRP in 10 weeks. Another 
group of participants from the aforementioned study underwent the same aerobic 
program in addition to a resistance exercise program, which resulted in significantly 
lower CRP (Donges, et al., 2010). In contrast, others have not observed changes to CRP 
despite exercise induced changes to body composition. For example, a six month 
intervention of aerobic training at 50% of maximal heart rate reduced participants’ 
body mass while CRP remained unchanged (Arsenault, et al., 2009). Another study 
resulted in decreased body fat and body mass after 16 weeks of moderate-intensity or 
high-intensity training, with no significant effects to CRP (Marcell, et al., 2005). As 
previously discussed, inflammation induces a large and quick increase in CRP, and 
therefore the variability of the CRP levels may fluctuate from day to day; best practice 
for measuring CRP in prolonged exercise trials is not yet clear.  
One study monitored participants’ CRP levels during a moderate-intensity, commuter 
cycling intervention (de Geus, et al., 2008). The intervention resulted in no change to 
body composition measures or CRP, compared to controls at 26 and 52 week follow-up 
(de Geus, et al., 2008). The results were consistent with a previous study from a 26 week 






Cross-sectional investigations provide evidence for an inverse relationship between 
cardiovascular fitness and total physical activity on CRP levels (Abramson & Vaccarino, 
2002; Panagiotakos, et al., 2005). Despite this, current evidence from randomised 
controlled trials generally indicates that exercise training is more likely to enhance CRP 
with concurrent loss of body mass, particularly from adipose tissue. Interestingly, 
weight-loss without change to PA habits has been reported to decrease CRP (Plaisance 
& Grandjean, 2006). Nevertheless, reduced CRP without improved body composition 
is generally limited to untrained or diseased populations such as CVD patients (Milani, 
et al., 2004; Goldhammer, et al., 2005) post-menopausal, breast cancer survivors (Fairey, 
et al., 2005) and elderly participants (Kohut, et al., 2006). Evidence for PA induced 
reductions in CRP without changes to body composition is sparse among younger and 
disease-free populations. Given the strong prognostic value of CRP as a leading 
biochemical marker of cardiovascular health, further study is warranted to enhance 
knowledge on the role of exercise to preclude adverse levels of CRP in seemingly 
healthy adults.  
 
 
2.10 Impaired glucose management 
Impaired glucose management is a condition by which blood levels of glucose are 
abnormally high due to resistance of insulin in peripheral cells and/or a lack of insulin 
34 
 
production from beta cells in the pancreas (Muniyappa, et al., 2008; Antuna-Puente, et 
al., 2011). This condition is clinically defined as fasting glucose levels ≥7.0 mmol/L or 
≥126mg/dL (Alberti & Zimmet, 1998; Mcauley, et al., 2001). Robust evidence supports 
the role of impaired glucose management in the progression of insulin resistance and 
type-2 diabetes, which increases risk for CVD. For example, insulin resistance is 
associated with dyslipidaemia, myocardial infarction, and hyperuricemia (Pyörälä, et 
al., 1987; Lillioja, et al., 1988; Stamler, et al., 1993; Wingard & Barrett-Connor, 1995; 
Haffner, et al., 1998). A variety of risk factors contribute to the development insulin 
resistance in adults. Age and genetic predisposition are non-modifiable risk factors, 
whereas obesity, accumulation of adipose tissue around the abdomen (android 
distribution), poor diet and physical inactivity are risks that can be reduced through 
behaviour change (eg. Ferrannini, et al., 1990; Wang, et al., 1989; Wareham, et al., 
2005). Physical activity is indisputably beneficial for people who have impaired blood 
glucose are insulin management (e.g. Sigul, et al., 2006). Exercise training enhances 
glucose management through several mechanisms including increased skeletal muscle 
dependence on lipids through enhanced mitochondrial density and greater capacity for 
beta-oxidisation, which spares glycogen (O'Gorman & Krook, 2008; Sigal, et al., 2006). 
Sensitivity of insulin is enhanced through increased signalling in skeletal muscle as well 
as improved glucose transport predominantly through increased concentrations of 
Glut-4 enzyme with frequent exercise (O'Gorman & Krook, 2008; Sigal, et al., 2006).   
The volume of exercise required by apparently healthy and normal-weight adults to 
reduce risk of insulin resistance is not very clear due to surprisingly few studies that 
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have investigated exercise training on glucose or insulin management in this 
population. Aerobic exercise training improved glucose and insulin dynamics in obese 
men with 100-150 min/wk of PA in 16 weeks (Leon, et al., 1979; Rice, et al., 1999) and 
in middle aged women with 12 weeks (Yamamoto, et al., 2007), and older obese men 
with combined aerobic and resistance exercises (Davidson, et al., 2009). Only one 
aforementioned study utilised the gold-standard method for determining insulin 
resistance, a euglycemic insulin clamp (Davidson, et al., 2009). The variety of 
methodology used by others (e.g. OGTT, HOMA, HbA1c) challenges efforts to directly 
compare results between studies, nevertheless, aerobic exercise appears to be beneficial 
in obese and in middle to older aged adults.  
In general, people who are insulin resistant can improve management of glucose and 
insulin through regular PA and the adaptations that improve insulin resistance have 
also been observed in healthy adults (O'Gorman & Krook, 2008). However, 
comparatively few have investigated insulin and glucose dynamics with exercise 
training in a healthy adult population. the intensity of the PA performed may be a 
determining factor in preventing insulin resistance in young adults.  High-intensity PA  
has been demonstrated to have a greater effect on insulin and glucose dynamics (Seals, 
et al., 1984; Tjønna, et al., 2008), albeit others have reported that intensity was of less 





Diabetes risk among physically active transport users 
Two studies were conducted to assess risk for developing type-2 diabetes among 
physically active transport users (Gordon-Larsen et al., 2009; Hu et al., 2003). In a cross-
sectional investigation, Gordon-Larsen et al. (2009) reported lower fasting insulin 
measures among men, but not women who actively commuted. However, their analysis 
did not control body composition, which is correlated with glucose management 
(Meigs, et al., 1998). In their prospective cohort study, Hu et al. (2003) reported reduced 
type-2 diabetes prevalence among those who use physically active transport. When 
controlling for gender, the effect remained significant for women, but not men. But 
gender differences diminished when BMI was controlled for (Hu, et al., 2003). To date, 
no known study has investigated blood glucose and insulin dynamics exclusively 
amongst habitual commuter cyclists, or in an intervention that promotes the new use 
of cycling for transport.  
 
Summary  
A strong association between risk for developing diabetes and risk for CVD has been 
established (Stern, et al., 1985; Rodriguez, et al., 1996). Epidemiological research 
suggests active commuting may reduce risk for developing type-2 diabetes (Gordon-
Larsen, et al., 2009; Hu, et al., 2003). However, direct risk factors for type-2 diabetes 
(i.e. insulin sensitivity / resistance) have not been investigated with commuter cycling. 
Interventions utilising other forms of PA have observed enhanced fasting insulin and 
glucose in adults. Thus, future research is warranted to clarify the relationship between 
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PA, insulin and glucose to establish whether commuter cycling is sufficient to reduce 
risk of developing insulin resistance and associated health impairments such as 
metabolic and cardiovascular diseases.  
 
 
2.11 Quality of Life 
Physical activity is correlated with improved mental health (Glenister, 1996). 
Specifically, PA increases emotional well-being and decreases anxiety and depression 
compared to sedentary people (Salmon, 2001). The commonly used Short Form 36 
questionnaire uses eight components to define and measure QOL in a health-related 
context, which includes vitality, physical functioning, mental functioning, bodily pain, 
general health perceptions, mental health, emotional functioning and social 
functioning (Ware Jr. & Sherbourne, 1992). 
Cross-sectional research has consistently demonstrated a correlation between time 
engaged in PA and health-related QOL. That relationship is described by a bell-shaped 
curve in which those who exercise the least and the most have inferior QOL to those 
in the two middle quartiles of time engaged in PA (Stewart, et al., 1993; Brown, et al., 
2003; Vuillemin, et al., 2005). Longitudinal studies generally support data from cross 
sectional studies, albeit evidence is less consistent (e.g. Partonen, et al., 1998; 
Malmberg, et al., 2005; Brand, et al., 2006; Tessier, et al., 2007). The longitudinal trials 
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however, have been criticised for a lack of instrument validation, inappropriate 
analyses and inadequate randomisation procedures (for review, see Bize, et al., 2007).  
 
Quality of life and commuter cycling 
In a non-randomised controlled trial, de Geus et al. (2008) explored the effects of 12 
months of moderate-intensity CC and leisure time PA over 150 min/day on health-
related QOL as measured by the Short Form 36 (Ware Jr. & Sherbourne, 1992). Cycling 
participants reported increases in Vitality and role limitation due to physical health 
over time, but not between groups, whereas Physical Functioning was enhanced over 
time and above controls (de Geus, et al., 2008). Cycling and control groups differed in 
some QOL variables at baseline, which decreases the internal validity of their between-
group QOL analyses (de Geus, et al., 2008). Nevertheless, within-subject improvements 
to QOL variables with commuter cycling are encouraging, but require confirmation. 
 
Summary 
People with habitual PA routines generally have lower occurrence of anxiety and 
depression. Some longitudinal studies support the role of PA on enhanced mood, but 
not all. Quality of life instruments also vary in quality between studies, further 
confounding generalisations on the role of PA and QOL. In the one study that measured 
QOL with commuter cycling, cycling enhanced some QOL measures, but cycling and 
control groups were different at baseline, which obscure the effects of commuter 
cycling on QOL parameters (de Geus, et al., 2008). Although acute increases in mood 
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with exercise are well established, whether a training effect can be observed in healthy 






The role of PA to reduce risk of CVD is indisputable. Even short-term PA interventions 
improved risk factors for CVD, however mixed findings exist for enhanced body 
composition, insulin resistance and C-reactive protein in healthy populations. Different 
initial values for parameters of health amongst participants in previous studies, as well 
as the different load and duration of PA, may have influenced the contrast in results 
between studies. This is particularly true for moderate-intensity PA trials, which are 
less likely to improve indices of health compared to high-intensity PA. Although both 
moderate and high-intensity PA is beneficial for health and longevity, trials with high-
intensity PA enhances health parameters in a shorter duration.  
The self-selected pace for commuter cycling is generally at a moderate-intensity (~60% 
V̇O2max) and performed for less than the public health recommendation of 150 min/wk 
of moderate PA. However, commuter cycling may assist with meeting public 
recommendations for PA when combined with existing leisurely PA and/or 
occupational PA. The role of commuter cycling on existing PA is unknown and largely 
under reported in research on healthy populations. 
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Epidemiological and cross-sectional research indicates a reduction of risk for CVD 
mortality and favourable changes to CVD risk factors amongst people who habitually 
use physically active modes of transportation. Short and long-term interventions of 
commuter cycling support epidemiological findings for cardio-respiratory fitness, with 
inconclusive findings for other parameters such as body composition, blood pressure, 
inflammation and cholesterol. Resting heart rate and fasting insulin have not been 
investigated in the context of commuter cycling.  
Barriers that prevent generalisations of which health parameters are likely to change 
with commuter cycling are due to a lack of repeatability in the parameters of health 
monitored, as well as varying duration of commuter cycling trials (i.e. 8 wk vs 52 wk). 
Generalisations of the benefits from commuter cycling are further confounded by the 
lack of control for existing levels of PA and EE before and during research studies. The 
role of novel commuter cycling on total daily PA and EE has not been investigated. 
Health parameters may have only improved minimally in current trials, in contrast to 
interventions with different exercise modes, due to a relatively small contribution of 
commuter cycling on total levels of EE and PA. Or it may be that commuter cycling 
doesn’t offer enough cardiovascular strain to enhance major CVD risk factors; only 
further investigation will enhance knowledge on this form of PA.   
Research on how commuter cycling may reduce risk for CVD, improve body 
composition and QOL is not yet complete. Further research is warranted to repeat and 
support existing findings and explore other health parameters that have not previously 
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been studied in the context of commuter cycling (i.e. insulin/glucose dynamics and 
resting heart rate). In doing so, a deeper understanding may develop for the 






CHAPTER THREE: Research Methods 
3.1  Overview 
To enhance knowledge of the health gains that may be achieved by introducing 
commuter cycling to the daily routine, a quasi-randomised controlled study was 
undertaken to evaluate effects of a 10 week commuter cycling intervention. Twenty 
eight men and women who commuted by motorised transport were allocated to cycling 
and control groups. Those in the cycling group were provided with bicycles and cycled 
to and from work for a minimum of 100 min/wk for 10 consecutive weeks, whilst the 
controls were asked to continue their existing transportation and lifestyle habits, and 
were provided with public transport or petrol vouchers. Existing PA and EE was 
monitored before and throughout the 10 weeks. Markers of cardiovascular health, body 
composition and quality of life were measured before and after the intervention in 
cyclists and controls. Furthermore, the intensity and caloric expenditure of commuter 
cycling were also measured. This study was approved by the University of Otago 
Human Ethics Committee, reference number 10/153. 
 
 
3.2 Power Analysis 
Two power analyses, to determine sample size, were conducted using published studies 
that implemented interventions similar in duration and physiological intensity as the 
one proposed. Maximal oxygen consumption (V̇O2max) as a measure of aerobic fitness 
was chosen as a primary outcome variable as it is highly correlated with reduced 
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cardiovascular disease risk and reduced morbidity. Thus, the first power analysis was 
performed on this variable and expected changes over this time period. The paired-
sampled analysis was conducted assuming an increase in V̇O2max of 14%, standard 
deviation of 15% and a power of 0.80 indicated a sample size of 13 in each group was 
necessary (Kukkonen-Harjula, et al., 1998). 
A second power analysis was conducted on high-density lipoprotein (HDL cholesterol), 
which is also correlated with cardiovascular health and expected to change with 
increased PA. A paired-sample analysis with an increase of 33%, and standard deviation 
of 27% and a power of 0.80 indicated a sample size of 14 participants per group (Spate-
Douglas & Keyser, 1999). Therefore a minimum of 28 volunteers were sought for 




3.3 Participant selection  
A questionnaire was distributed to prospective participants who responded to fliers and 
emails advertising the study. The questionnaire assessed physical activity readiness and 
lifestyle factors associated with their current work, travel and PA habits (Appendix I). 
Exclusion criteria included smoking, active commuting, unemployed or working from 
home, a BMI greater than 30, under the age of 20 or over the age of 55, or participating 
in a structured training program, training to compete in sport and contraindications to 
exercise as defined in the Physical Activity Readiness Questionnaire (Thomas, et al., 
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1992). Ninety-six individuals applied for the study and 33 (18 men and 15 women) met 




3.4 Testing overview 
Eligible participants were invited to the School of Physical Education research 
laboratory for two testing sessions prior to the intervention and those allocated to the 
cycling group underwent a third session at the Dunedin Public Hospital (Figure 3.1). 
In response to the invitation, one male declined and one female discovered she was 
pregnant and withdrew from the study. Measures taken at the first testing session were 
quality of life (QOL) questionnaire, skin-fold thickness, incremental V̇O2max with a 
cycle ergometer and power output at V̇O2max.  Thirty one people (17 male, 14 female) 
participated in the first testing session. One male did not complete the V̇O2max test and 
another was excluded from participation upon disclosing plans for overseas travel 
during the intervention period. Twenty nine people (15 males, 14 females) completed 
the first testing session and were invited to the second testing session. Upon group 
allocation to cycling (CYC) and control (CON) groups, one male withdrew from the 
study. Twenty-eight participants (14 male, 14 female) underwent the second testing 
session, which involved a physical activity questionnaire, resting measures of heart rate 
and blood pressure, blood sample, and instructions for completion of diet records and 
PA log books. All 28 participants completed the second testing session. The 14 
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participants in CYC underwent a third testing session at the Dunedin Public Hospital 






Time period  Measures 
14 – 8 days before 
intervention 
  QOL, Skinfolds, V̇O2max 
7 – 1 days before 
intervention 
wk 0  Resting HR & BP, WHR, blood sample, IPAQ, fasted BM, diet record,        
log book, DXA (CYC only) 
 wk 1  Log book, fasted BM 
 wk 2  Log book  
 wk 3  Log book 
 wk 4  Log book, fasted BM, diet record, IPAQ, HR sampling (CYC only) 
Intervention wk 5  Log book, fasted BM, sub-maximal V̇O2 cycle test (CYC only) 
Period 
wk 6  Log book 
 wk 7  Log book 
 wk 8  Log book, fasted BM, diet record, IPAQ, HR sampling (CYC only) 
 wk 9  Log book, fasted BM 
 wk 10  Log book 
1 – 7 days after 
intervention 
  Resting HR & BP, WHR, blood sample, IPAQ, fasted BM, DXA (CYC 
only) 
8 – 14 days after 
intervention 
  QOL, Skinfolds, V̇O2max 
Figure 3.1: Timeline of data collection. Abbreviations: wk (week), QOL (quality of life), V̇O2max 
(maximal oxygen consumption), HR (heart rate), BP (blood pressure), WHR (waist-to-hip ratio), IPAQ 
(international physical activity questionnaire), BM (body mass), DXA (Dual-energy X-ray 













3.5 Preliminary testing measures 
The preliminary testing session took place between fourteen and eight days before the 
intervention (Figure 3.1). At least two days before the first testing session, participants 
were informed of the testing procedures and preparedness for the test (i.e. appropriate 
clothing for exercise, hydration, no meals within 2 hours of testing, abstain from 
vigorous or otherwise exhausting PA the day prior). Upon arrival to the lab, participants 
completed an informed consent to participate. 
 
Health-related quality of life 
Health-related QOL was assessed by the Short Form 36 questionnaire (SF-36, Ware & 
Sherbourne, 1992). The questionnaire measured eight multi-itemed variables for 
physical, social and mental functioning. The variables include: ten-item physical 
functioning, two-item social functioning, four-item role limitations due to physical 
problems, three-item role limitations due to emotional problems, five-item mental 
health, four-item mental energy and vitality, two-item pain, five-item perception of 
general health, and a single-item question on changes to health in the previous year.  
 
Skin folds 
Skinfold thickness was measured at four sites (triceps, biceps, sub-scapular and supra-
iliac) to the nearest 0.2mm with John Bull callipers (British Indicators Ltd., St Albans, 
England). Measures were performed in duplicate and measures with variability over 
one millimetre were repeated a third time and the closest two measures used. Body 
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density and percentage body fat were calculated with formulas from Durnin & 
Womersley (1974). 
 
Maximal oxygen consumption 
An incremental exercise test to exhaustion was performed on a Velotron Elite cycle 
ergometer (RacerMate Inc., Seattle, Washington, USA) to determine V̇O2max and 
maximum power (watts). A silicon face mask (Hans Rudolph, Inc, Kansas City, USA) 
was used to capture respiratory gases, measured breath-by-breath with open circuit 
spirometry (Cosmed Cardio Pulmonary Exercise Testing, CosmedSrl, Rome, Italy) and 
averaged into 30 s blocks.  
The protocol for the cycle test started with a five minute warm up at 75 w with a 
pedalling cadence between 80-95 revolutions per minute (rpm). Visual and verbal 
feedback was used to assist with maintaining pedalling cadence. The protocol started at 
100 w and increased in 50 w increments every three minutes until a heart rate (HR) of 
165 BPM was achieved. After 165 BPM, stages were increased in 25 w increments until 
exhaustion, defined by plateau in V̇O2 with increased workload. If a plateau was not 
observed, exhaustion was defined as inability to pedal greater than 60 rpm in addition 
to one of the following criteria: RER of ≥ 1.1 or maximal age-predicated HR (± 10 BPM). 
A warm-down was then performed on the cycle ergometer for a minimum of five 




If participants were unable to complete the V̇O2max protocol, a second attempt was 
permitted before exclusion from the study, which took place prior to the start of the 
second testing session. Two females completed the test on second attempt in which the 
resistance on the cycle ergometer was reduced to a 50 w warm up, with the first stage 
at 75 w and 25 w increases every three minutes until exhaustion, as defined above.   
 
 
3.6 Second testing session 
Overview 
The second testing session took place in the seven days prior to the intervention (wk 0, 
Figure 3.1). Participants were encouraged to select an appointment time between 
6:30am and 10am to suit their normal morning routine and were asked to arrive at least 
48 hours after their last bout of moderate or high intensity exercise, at least 24 hours 
from any exercise, at least a 24 hour fast from alcohol and 12 hour fast from food and 
caffeinated beverages. Upon arrival to the laboratory, body mass and waist and hip 
circumferences were measured, participants were then fitted with a recordable HR 
monitor and seated to complete a physical activity questionnaire, followed by rest in 
the supine position. Blood collection consumables were hidden from participants’ view 
until BP and HR measures were collected. While participants remained supine, blood 
collection was performed. Upon completion of testing, participants were provided with 
breakfast and were instructed on procedures for completing a four-day weighed food 
record and log book (if not already advised).  
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International Physical Activity Questionnaire 
Physical activity was assessed with the short form version of the International Physical 
Activity Questionnaire (IPAQ). In a systematic review, total PA assessed by the short 
form IPAQ was correlated between 0.09 and 0.39 to objective measures of PA, whereas 
vigorous and moderate intensity PA had a stronger, albeit more variable  correlation (-
0.18 and 0.76) compared to objective PA measures (Lee, et al., 2011). 
 
Body composition and mass measures 
Fasted body mass, waist and hip circumferences were performed after a 12 hour fast 
from food. Participants were instructed to void and asked to remove excess clothing 
before body mass measure on electronic scales (Model 770, Seca alpha, Hamburg, 
Germany). Participants were clothed for waist and hip circumference measures, which 
were performed in duplicate by the same technician for pre and post-intervention 
testing. Pre-intervention results were blinded from the technician during post-
intervention testing. 
 
Resting blood pressure 
Systolic and diastolic BP was manually recorded for the first and fifth Korotkoff sounds 
from the antecubital artery. Blood pressure measurements were performed in duplicate 
with a mercury sphygmomanometer (Nihon Seimitsu Sokki Co. Ltd., Gunma, Japan) 
and stethoscope by the same technician for all participants during pre and post-
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intervention testing. Pre-intervention results were blinded from the technician during 
post-intervention testing.  
 
Resting heart rate 
Resting heart rate was recorded with a Polar RS400 (Polar Electro Inc., Kempele, 
Finland) throughout 15 min of supine rest. Data was exported to Microsoft Excel for 




Plasma samples for fasting insulin, glucose, triglycerides, cholesterol (HDL and LDL), 
and C-reactive protein (CRP) were collected after resting HR and BP measures. A 
technician drew blood from an antecubital vein and collected in plastic 6 ml BD 
vacutainers (BD New Zealand, Auckland, New Zealand) with 10.8mg K2 EDTA 
coagulant. Vacutainers were gently inverted eight times, then immediately spun in a 
~4℃ centrifuge (Beckman GS-15R, Beckman Instruments, Solna, Sweden) at 3000 rpm 
for 10 min. Plasma was then extracted from the vacutainer into four micro centrifuge 
tubes in the following amounts: 200 𝜇𝐿 for glucose, 400 𝜇𝐿 for insulin, 350 𝜇𝐿 for CRP, 
500+ 𝜇𝐿 for cholesterol and triglycerides. Plasma samples were frozen at -80℃ and 






Estimated energy intake and macro nutrient intake was assessed by weighed food 
records at weeks zero, four and eight. Participants were provided with verbal and 
written instructions, food scales, and portion-size picture book to measure total food 
intake for three weekdays and one weekend day in the seven days prior to the 
intervention. Fasted body mass was measured before and after the four day food dairy. 
Although food records were kept by both participant groups, only CYC results were 
intended for analysis. CON performed the food records to ascertain any effects of 
keeping a food diary, which has previously been shown to affect eating behavior 
(Poslusna, et al., 2009). We acknowledge that the analyses of EE estimates would be 
more robust if performed on both groups. However, availability of human resources 
prevented data entry of food records from CON. Energy and macronutrient intakes of 
CYC were assessed with Diet Cruncher Software (Way Down South Software, 
Dunedin, New Zealand).  
 
Physical activity log books 
Time engaged in physical activity prior and throughout the intervention was recorded 
with a daily PA log book. Participants were provided with log books and access to a 
website specific to this study, depending on their preference, to record PA information. 
To establish baseline PA levels, a daily log was kept by all participants on the duration 
of light activities lasting 10 or more minutes, and moderate and vigorous-intensity PA 
lasting at least five minutes in duration, for one week prior to the intervention (wk 0) 
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and throughout the study. To improve reliability of perceived intensity recorded in 
activity diaries, log books including definitions and examples for activities of moderate 




3.7 Group allocation 
Twenty-eight participants were randomised into CYC and CON with stratification for 
gender and V̇O2max. Each participant was paired with one other participant of the same 





3.8 Third testing session 
Participants allocated to CYC underwent DXA scans at the Dunedin Public Hospital 
before and after the intervention. Lean and fat masses were determined for the whole 
body, as well as for legs, arms, trunk, waist and hips using methods from Taylor et al. 
(1998). Funding for DXA was adequate for 28 scans only and statistical power was 
insufficient to perform scans on a subset of participants from both groups at both time 
points. Therefore DXA scans were performed on CYC before and after the intervention 





3.9 Bicycle safety, maintenance and route selection 
Each participant in the intervention group was met with individually to discuss road 
rules regarding bicycle use and common hazards from various road surfaces and road 
users. During the session, participants were provided with an information pack which 
outlined the bicycle function and road rules. A discussion of potential route choices 
followed, including an action plan for the days they intend to cycle and a backup plan 
if a scheduled active commute was missed. Participants were instructed to report the 
occurrence illness during weekly phone calls / emails with research assistant, if A) was 
a cause for not meeting the minimum 100 min/wk of cycling or B) if it was a week of 
data collection (e.g. body mass and food diaries wks 4 and 8, submaximal testing wk 5, 
or testing sessions before/after the intervention). Additionally, strategies for managing 
weather, clothing choices and transport of work materials (i.e. business suits, briefcases, 
text books etc.) were discussed and questions answered.  
During the third week of the intervention period, two bicycle maintenance clinics were 
conducted to support participants in learning how to replace a bicycle tube, perform a 




3.10 Intervention  
Initiation of commuter cycling was staggered based on timing of recruitment, testing 
and availability of lab equipment, with six females and one male starting seven days 
after the other seven CYC participants. CYC were asked to cycle commute at least 20 
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min/day, 3-5 days/wk at a self-selected intensity for 10 consecutive weeks. Participants 
were encouraged to accumulate at least 150 min/wk of commuter cycling. However, a 
minimum ride time of 100 min/wk, accumulated on three or more days was necessary 
to remain in the project. Participants were allowed one week of less than 100 minutes 
of cycling (e.g. illness, travel) but were made up by adding an extra week to the 
intervention. CYC were provided with bicycles, high-visibility wet-weather clothing, 
front and rear bicycle lights, tube repair kits, and a portable tire pump, but supplied 
their own helmet. Correspondence with participants took place weekly to ensure 
adherence and completion of PA log books and offer any assistance required by the 
participants. Correspondence was performed in person when data was collected on 
weeks four, five, seven and eight. Remaining contact took place by email or phone, 
based on the participants’ preference. As reward for participation in the study, 
participants in the CYC were given the bicycles and accessories provided to them for 
the intervention.  
CON followed the intervention period of the first seven CYC participants. CON were 
asked to maintain their present transport, physical activity and dietary habits but were 
encouraged to record any changes they made into their PA log book/website entries. 








3.11 Intermediate measures during the intervention period 
Levels of physical activity, food intake, body mass and HR sampling were monitored at 
regular intervals during the intervention (Figure 3.1). 
 
Monitoring physical activity 
The IPAQ (short form) administered at week zero, was repeated weeks four and eight. 
The questionnaire was implemented in pencil and paper form at the research 
laboratory.  
 
Monitoring dietary intake  
The four-day weighed food record performed week zero, was repeated on weeks four 
and eight. Body mass measurements were performed before and after completion of 
each four-day food record, within a seven-day window. 
 
Heart rate sampling 
CYC were instructed to wear a downloadable HR monitor (Polar RS400, Polar Electro 
Inc., Kempele, Finland) during all waking hours on week four and for each one-way 
cycle commute on week eight. Heart rate data for their commuting activities was 
extracted from the data set to determine the relative work rate (percent of maximum 





Sub-maximal cycling test 
At week five, CYC performed an incremental exercise test on a cycle ergometer to 
determine steady state oxygen consumption at various cycling intensities. These data 
were used to estimate energy expenditure of commuter cycling based from HR data 
collected at weeks four and eight. Equipment used for the test was the same as described 
for the V̇O2max test in the first testing session. 
Participants were fitted with HR monitors and warmed up for 5 minutes with a self-
selected cadence between 50 to 100 W of resistance, depending on fitness level. For 
warm up, participants were instructed to use a pedalling cadence similar to their normal 
bicycling habits and were instructed to maintain the same cadence throughout the sub-
maximal test. A visual representation of their real-time cadence was present on a 
computer screen in front of the cycle ergometer. 
The exercise test started at 40% of V̇O2max and increased in 10% increments until 
termination at 80% of V̇O2max. Resistance on the cycle ergometer corresponding to 
targeted percentage of V̇O2max was calculated based participants’ power output from 
their pre-intervention V̇O2max test. Each workload was performed for five minutes or 
until a steady state had been achieved for 60 s. Respiratory gases were monitored 
continuously throughout the sub-maximal test for total oxygen consumption and for 






3.12 Post-intervention testing 
The three testing sessions performed by participants prior to the intervention were 
repeated upon completion, with replication of the procedures and in the order that the 
earlier tests were implemented (Figure 3.1). Measures of PA and diet habits were 
excluded from post-intervention testing as they were monitored to ascertain changes 





3.13 Analyses  
Blood measures 
Plasma samples of C-reactive protein, total cholesterol, HDL cholesterol and 
triglycerides were analysed with COBAS Mira Plus analyser (Roche Diagnostic, Basel, 
Switzerland). Participants’ pre and post-intervention samples were analysed in the 
same batch. LDL cholesterol was determined by Friedewald equation, where 
cholesterol values are expressed as mmol/L (Friedewald, et al., 1972). 
 
LDL Chol. = Total Chol.  – (Triglycerides ÷ 2.18)  -  HDL Chol. 
Glucose was analysed in duplicate with a Cobas c 111 (Roche Instrument Centre, 
Rotkreuz, Switzerland) and insulin was analysed with electrochemiluminescence 
method using analyser Elecsys2010 (Roche/Hitachi, Tokyo, Japan). Homeostatic model 
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assessment for insulin resistance (HOMA-IR) was calculated using the method by 
Matthews et al. (1985).   
HOMA(IR) = (Insulin (uU/ml) × Glucose(mmol/L)) ÷22.5 
Defrost and preparation of plasma samples was performed in accordance to 
manufacturer’s instructions. Plasma was analysed with kits from Roche/Hitachi (Roche 
Diagnostics, Mannheim, Germany). The coefficient of variation (CV) for glucose was 
(1.6%), insulin (1.6%), cholesterol (1.7%), HDL cholesterol (4.7%), triglycerides (1.2%) 
and CRP (6.7%).  
 
Energy expenditure of commuter cycling 
The HR Flex method was utilised to differentiate active from non-active periods in HR 
dataset by defining PA as 10 BPM above the highest average sedentary HR (Spurr et al., 
1988). To define physiological intensity (i.e. V̇O2max %) of cycling, week four HR data 
was compared to the initial V̇O2max test, whereas HR data from week eight was 
compared to the post-intervention test. To determine energy expenditure of commuter 
cycling, HR from cycling was compared to HR from the week five submaximal test and 
corresponding steady-state V̇O2 value. Calculation for energy expenditure was 






Energy expenditure from weighed food records 
Energy expenditure was estimated based on energy intake at weeks zero, four and eight 
with correction for change in fasted body mass. Change in mass was added/subtracted 
to energy intake with the assumption that one pound (0.45kg) of mass equals 14,644 kJ 
(Wishnofsky, 1952; McArdle, Katch and Katch, 2001).  





3.14 Statistical Analyses 
Overview 
Statistical Packages for the Social Sciences (SPSS, Version 20.0, SPSS INC, Chicago, IL) 
was used to carry out statistical analysis, with significance set at P ≤ 0.05. Paired t-tests 
were performed for measures analysed from CYC only (i.e. DXA, food records), 
repeated measures ANOVA were used to detect any time-by-group interactions with 
measures collected in both groups at three or more time points (i.e. PA). The percentage 
change between pre and post-intervention measures was performed on data collected 
at two time points (e.g. body composition, cardiovascular parameters, quality of life) 
and analysed by one-way ANOVA with group (i.e. CYC, CON) as independent variable.  
 
Preliminary analysis 
The use of ANOVA assumes normality of the distribution of data (Tabachnick & Fidell, 
2007). Each variable was tested for normality with Shapiro-Wilk statistic prior to use 
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in analysis. A significant (P ≤ 0.05) Shapiro-Wilk result indicates a violation of the 
assumption of normality, in which case a transformation of the data was performed 
prior to further analysis (Tabachnick & Fidell, 2007). Outliers were included in analyses 
unless instrumentation error or lack of participant compliance to research procedures 
was the suspected cause for the inconsistent data value, in which case the data were 
removed from the analysis. Whether a transformation was performed and the type of 
transformation used is indicated in Chapter Four.  
In addition to the assumption of normality, repeated measures ANOVA also has the 
underlying assumption of sphericity and homogeneity of variance (Tabachnick & 
Fidell, 2007). A significant (P ≤ 0.05) result from Mauchly’s Test of Sphericity indicates 
the assumption of sphericity is violated. In this case, results with Greenhouse-Geisser 
correction are reported. Homogeneity of variance was examined with Levene’s test of 
Equality of Error Variances with alpha set at P ≤ 0.05. All data are presented as mean ± 
standard deviation, unless indicated otherwise.  
 
Physical activity  
Total and MVPA was analysed with a two-way analysis (group by time) with repeated 
measures ANOVA to compare the change from baseline PA (min/wk) between groups 
each week of the intervention. Mean change in PA from baseline for weeks one 
through ten combined was analysed by one-way ANOVA for group difference for total 
PA and combined moderate and vigorous PA. Similarly, to determine if time engaged 
in non-cycling PA changed, total PA (minus cycling) and moderate and vigorous PA 
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(minus cycling) was analysed by one-way ANOVA for mean change from baseline to 
weeks one through ten combined.  
A two-way analysis (group by time) with repeated measures ANOVA was used to 
compare group difference in the change of PA (min/wk) from baseline measured by 
IPAQ at weeks four and eight. The analysis included PA and EE at vigorous-intensity, 
moderate-intensity, combined moderate and vigorous activity, but not for total PA due 
to low compliance on the 7-day recall for the amount of time spent walking in IPAQ. 
Data are presented as median and inter-quartile range, as recommended by the IPAQ 
research group (Sjöström, et al., 2005). 
 
Food records 
Repeated measures ANOVA was used to assess change from baseline for total energy 
intake (kJ/day), total and percentage intake from carbohydrates, fat and protein, and 
estimated energy expenditure (kJ/day) at weeks four and eight for CYC. 
 
Body composition 
One-way ANOVA with group as a factor was used to determine the percentage change 
in BMI, mass, sum of skin folds, body fat, hip circumference, waist circumference, and 
waist-to-hip ratio from baseline. Paired t-tests were used to measure differences 
between pre and post-intervention DXA scans for CYC. The analyses on body 
composition measures were repeated using sex as a factor to detect any differences 




Percentage change in V̇O2max, resting HR, blood pressure and blood parameters were 
analysed with one-way ANOVA, with group as a factor. Triglycerides, LDL-cholesterol 
and C-reactive protein yielded significant (P < 0.05) results from the Shapiro-Wilk 
statistic and were log-transformed prior to analysis.  
 
Quality of life questionnaire 
Each of the eight multi-itemed variables of the SF36 survey were summated and 
transformed to a scale of 0 (worst state of health) to 100 (best state of health) (Ware, et 
al., 2000). The percentage change from baseline was analysed with one-way ANOVA, 
with group as a factor. 
 
Other Measures  
Percentage change for fasting insulin and glucose, HOMA and maximum power 










CHAPTER FOUR: Results 
 
4.1  Compliance  
Twenty-seven participants completed intervention testing. Three CON participants (2 
female, 1 male) did not complete all intermediate measures performed during the 
intervention (i.e. log books, food records & IPAQ). Two of these aforementioned 
participants completed post-intervention testing and one female withdrew due to 
recurring illness. All 14 CYC participants completed the intervention. However, one 
female CYC participant was excluded from analysis upon her admission that she was 
commuter cycling prior to the intervention.  
 
Intervention  
Participants reported cycling for 148 ± 38 min/wk, with a range of 105 – 248 min/wk 
and this remained consistent (P = 0.82) (Figure 4.1a). Females cycled a similar amount 
as males (168 ± 59 min/wk, 131 ± 49 min/wk, resp.) and this did not change over time 




Figure 4.1a Time spent (mean ± SD) commuter cycling (n = 13) each week of the 







































Figure 4.1b Time spent (mean ± SD) commuter cycling each week of the intervention 
period by males (n = 7) and females (n = 6) (ANOVA: Time P = 0.86, Group P = 0.53, 









































Both groups had a high prevalence of self-reported illness throughout the intervention 
period (Figure 4.1c). When post-intervention testing was delayed due to illness, testing 
was rescheduled three days upon relief of symptoms for CON. When post-intervention 
testing was delayed to illness for CYC, testing was rescheduled upon alleviation of 
symptoms and after resuming commuter cycling for the same number of days that 
cycling was not performed due to illness (e.g. seven days of illness resulted in seven day 































Figure 4.1c Incidence of self-reported illness where each dot represents either one 




4.2  Participant Characteristics 
Characteristics of participants who completed intervention testing are summarised in 
Table 4.2. Fasted body mass was greater (P = 0.01) in CYC than CON and a trend (P = 
0.06) for BMI to be greater in CYC than in CON at baseline was observed (Table 4.2). 





Table 4.2 Baseline physical characteristics (mean ± SD) for cycling and control 
groups at baseline. 
BMI, body mass index; V̇O2max, maximal oxygen consumption. 





4.3  Commuter Cycling  
Duration 
Participants cycled 65 ± 38 min per round trip, which is the total time of daily cycling 
to and from work combined. This was determined by the monitoring of heart rate 
whilst commuting at wk 4 and wk 8. Mean round trip duration was similar (P = 0.51) 
between wk 4 and wk 8 (wk 4 66 ± 39, wk 8 64 ± 38 min). One-way commute to work 
was shorter in duration (P = 0.05) than the commute home at wk 4, but not at wk 8 (P 












Female n = 6 39.2 ± 9.0 75.9 ± 8.5 25.8 ± 2.9 72.3 ± 0.4 30.5 ± 3.9 
Male n = 7 38.0 ± 6.0 80.7 ± 9.5 26.3 ± 1.9 33.3 ± 0.9 40.7 ± 8.9 
Total n = 13 39.0 ± 7.0   76.8 ± 10.7 25.7 ± 2.7   2.8 ± 0.8 35.9 ± 8.2 
Control group      
Female n = 6 32.5 ± 6.5 68.7 ± 8.5 24.8 ± 2.4 32.2 ± 0.4 31.8 ± 7.1 
Male n = 7 36.0 ± 7.6 70.8 ± 5.2 23.7 ± 2.3 23.1 ± 0.6 44.4 ± 8.4 




Based upon the V̇O2max tests and heart rates during commuting, commuter cycling was 
performed at 65 ± 9% of HRmax, which correlates with 56 ± 11% V̇O2max from pre-
intervention V̇O2max tests. Intensity of commuter cycling was similar at wk 4 and wk 
8 (Table 4.3). Heart rate response to cycling was higher during travel home from work 
at wk 4 (P = 0.02) and wk 8 (P = 0.04) than travel to work (wk 4: to work 60 ± 12%, to 
home 69 ± 7%; wk 8: to work 65 ± 10%, to home 69 ± 10% HRmax) (absolute values in 
Table 4.3). Similarly, cycling intensity expressed as percentage V̇O2max was higher 
during travel home from work at wk 4 (P = 0.02) and wk 8 (P = 0.02) than travel to 
work (wk 4: to work 52 ± 18%, to home 60 ± 12%; wk 8: to work 46 ± 17%, to home 61 
± 9% V̇O2max) (absolute values in Table 4.3).  
 
Energy expenditure 
Mean energy expenditure of a round trip commute, as estimated by heart rate while 
commuting and V̇O2 data from a lab-based sub-maximal cycling test was 2435 ± 1774 
(kJ). Roundtrip commute at wk 4 was similar (P = 0.64) to wk 8 (wk 4 2397 ± 1820, wk 
8 2460 ± 1820 kJ).  
Energy expenditure was lower for travel to work than travel home from work at wk 4 
(P = 0.03) and a similar trend occurred at wk 8 (P = 0.07) (wk 4: to work 987 ± 1104, to 






Table 4.3 Physiological measures of intensity (mean ± SD) while commuter 
cycling (n=13) at wk 4, wk 8 and average of wk 4 and 8. 
HR, heart rate; V̇O2, oxygen consumption; EE, energy expenditure 
a Paired t-test between to work and to home  
b




4.4  Levels of Physical Activity 
International Physical Activity Questionnaire 
At wk 0, the majority of participants had moderate levels of physical activity, defined 
by IPAQ as 30 min of moderate intensity PA on most days per week (CYC n = 10, CON 
n = 9). Several participants (CYC n = 2, CON n = 2) had high PA levels, defined as 60 
min of daily moderate activity or 30 min of vigorous activity above basal PA level (basal 
defined as 5,000 steps/day or the PA equivalent). Some participants had low levels of 
PA, defined as not meeting the requirements for moderate or vigorous categories (CYC 
n = 1, CON n = 2).  
Average To work To home P a Round trip  
HR (b · min
-1) 111 ± 241  129 ± 119 0.02 120 ± 20  
V̇O2 (l · min
-1) 1.4 ± 0.5  1.8 ± 0.5 0.02   1.6 ± 0.6  
EE (kJ · min
-1
) 31 ± 11  39 ± 12 0.05   35 ± 12  
Wk 4 To work To home P a Round trip  
HR (b · min
-1) 111 ± 220   127 ± 100 0.03 119 ± 12  
V̇O2 (l · min
-1) 1.4 ± 0.4 1.8 ± 0.6 0.03   1.6 ± 1.4  
EE (kJ · min
-1
)      29 ± 8     38 ± 80 0.01 33 ± 8  
Wk 8 To work To home P a Round trip P b 
HR (b · min
-1)    112 ± 29   130 ± 150 0.02 121 ± 19 0.39 
V̇O2 (l · min
-1) 1.4 ± 0.6 1.9 ± 0.5 0.03   1.6 ± 1.4 0.54 
EE (kJ · min
-1




Table 4.4 Median (upper and lower quartiles) weekly physical activity from 
International Physical Activity Questionnaire in control (CON n = 11) and commuter 
cycling (CYC, n= 12) groups before (wk 0) and 4 weeks (4 wk) and 8 weeks (8wk) into 
the intervention. 
MVPA, moderate and vigorous intensity physical activity combined; VPA, vigorous 
intensity physical activity; MPA, moderate intensity physical activity. 
a P = 0.005 ANOVA change from baseline (P > 0.05 for group effect and time-by-
group interaction) 
b P = 0.05 ANOVA change from baseline (P > 0.05 for group effect and time-by-group 
interaction) 




There were no group differences at wk 0 for combined moderate and vigorous PA 
according to reported minutes active in defined intensity categories (CYC 160 ± 119, 
CON 169 ± 262 min/wk, P = 0.91), vigorous PA (CYC 85 ± 100, CON 24 ± 32 min/wk, 
P = 0.09) nor moderate PA (CYC 75 ± 82, CON 141 ± 257 min/wk, P = 0.39).  
Moderate and vigorous PA combined changed (P = 0.005) from baseline and a trend (P 
= 0.06) for PA to be reported higher in CYC than CON was observed (wk 4: CYC ∆114 
± 131, CON ∆0 ± 119; wk 8: CYC ∆38 ± 117, CON ∆–67 ± 200 min/wk) (absolute values 
in Table 4.4). Vigorous PA also changed from baseline (wk 4: CYC ∆55 ± 85, CON ∆26 
± 70; wk 8: CYC ∆20 ± 78, CON ∆–5 ± 31 min/wk) (Table 4.4) but the large variation 
 wk 0  wk 4  wk 8 
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between individuals precluded a significant difference between groups or interaction 
(Time P = 0.05, Group P = 0.90, Interaction P = 0.38) (Table 4.4). Moderate PA changed 
from baseline (wk 4: CYC ∆45 ± 75, CON ∆-26 ± 176; wk 8: CYC ∆5 ± 79, CON ∆– 70 
± 193 min/wk) and there was no difference between groups nor was there a significant 
interaction (Time P = 0.03, Group P = 0.20, Interaction P = 0.93) (Table 4.4). 
 
Physical Activity Log Books  
The contribution of cycling to total weekly PA, as recorded in log books, in CYC and 
CON is illustrated in Figure 4.4a. Groups were similar at wk 0 for mean total PA (P = 
0.68) (Figure 4.4a) and for combined moderate and vigorous PA (P = 0.42) (Figure 4.4b).   
Difference from baseline in weekly total PA did not change over time and there was no 
difference between groups over the ten week period (Time P = 0.19, Group P = 0.24, 
Interaction P = 0.46) (absolute values in Figure 4.4a). Further, mean change in PA of 
weeks one through ten combined was similar (P = 0.24) to wk 0 (absolute values in 
Figure 4.4c, Appendix II). Difference from baseline in reported weekly moderate and 
vigorous PA was higher in CYC than CON, but no change was detected over time nor 
was there a significant interaction (Time P = 0.26, Group P = 0.003, Interaction P = 
0.31) (absolute values in Figure 4.4b). However, when analysed as the mean of weeks 
one through ten of moderate and vigorous PA, CYC increased (P = 0.003) from baseline 
compared to CON (CYC ∆112 ± 101, CON ∆-10 ± 82 min/wk) (absolute values in Figure 




Figure 4.4a Total physical activity per week (mean ± SD) in control (n = 12) and commuter 
cycling (n = 13) groups, the latter differentiating that from cycle commuting and other 
physical activities (ANOVA for difference from baseline: Time P = 0.19, Group P = 0.24, 




Figure 4.4b Vigorous and moderate intensity physical activities combined per week 
(mean ± SD) in cycling (n=13) and control (n=12) groups (ANOVA for difference from 
































































































Non-cycling physical activity from log books 
Weekly reported total PA unrelated to commuter cycling did not change over time and 
there was no difference between groups (Time P = 0.22, Group P = 0.23, Interaction P 
= 0.37) (Figure 4.4e). Further, the ten week average for time engaged in PA unrelated 
to commuter cycling was unchanged (P = 0.23) from wk 0 (absolute values in Figure 
4.4f, Appendix II ). Weekly moderate and vigorous PA did not change over the 10 week 
period and there was no difference between groups (Time P = 0.36, Group P = 0.81, 
Interaction P = 0.13) (Figure 4.4g).  Likewise, moderate and vigorous PA for weeks one 
through ten combined also did not change (P = 0.81) (absolute values in Figure 4.4h 
Appendix II). In conclusion, no change to PA outside of time spent commuter cycling 







Figure 4.4e Total physical activity per week (mean ± SD) outside of commuter cycling in 
cycling (n=13) and control (n=12) groups (ANOVA for difference from baseline: Time P 




Figure 4.4g Time spent in vigorous and moderate intensity physical activities combined 
(mean ± SD) outside of commuter cycling in cycling and control groups (ANOVA for 




































































































































4.5 Energy Expenditure  
International Physical Activity Questionnaire 
Energy expenditure calculated as metabolic equivalent minutes per week (MET-
min/wk) for combined MET-min from moderate and vigorous PA (P = 0.16), and 
moderate PA (P = 0.39) but a trend (P = 0.07) for vigorous PA to be greater in CYC than 
CON was observed (Table 4.5a).  
Difference from baseline for MET-min/wk from moderate and vigorous PA changed 
overtime (P = 0.005), but no main group effect (P = 0.16) or interaction (P = 0.25) were 
observed (wk 4: CYC ∆666 ± 823, CON ∆136 ± 413; wk 8: ∆CYC 134 ± 882, CON ∆-103 
± 567 MET-min/wk). MET-min/wk from moderate PA transiently increased over time 
at wk 4 (P = 0.05), with no observed changes to the main group effect (P = 0.66) or 
interaction (P = 0.77) (wk 4: CYC ∆93 ± 429, CON ∆5 ± 309; wk 8: CYC ∆-56 ± 407, 
CON ∆-107 ± 477 MET-min/wk) (Table 4.5a). MET-min/wk from vigorous PA also 
increased over time (P = 0.02) and again no observed changes between groups (P = 0.10) 
or interaction (P = 0.22) (wk 4: CYC ∆572 ± 654, CON ∆130 ± 328; wk 8: CYC ∆190 ± 









































































































































































































































































































































































































































































































































































































































No change in total energy, carbohydrate, fat or protein intakes were observed over time 
in CYC (Table 4.5b). Similarly, estimated energy expenditure from food records with 
correction for body mass changes resulted in no change (P = 0.26) over time in CYC 
(Figure 4.5).   
 
 
Table 4.5b Total energy intake, carbohydrate intake, fat intake and protein intake for 
13 commuter cyclists at week 0 and weeks 4 and 8. 
 Wk 0  Wk 4  Wk 8    P a 
TEI (kJ/d) 10,206  ± 2,236  10,367 ± 1,623   9,949  ± 2,735  0.52 
CHO (g/d)      316 ± 117  320  ± 68  303 ± 120  0.71 
CHO (E%)        52 ± 9    52  ± 8    51  ± 7  0.34 
Fat (g/d)        86 ± 22    91  ± 22    87  ± 18  0.54 
Fat (E%)        32 ± 7    32  ± 6    33  ± 5  0.67 
Protein (g/d)        91  ± 18    86  ± 18    85  ± 20  0.92 
Protein (E%)        15  ± 3    14  ± 2    15  ± 2  0.16 
TEI, Total energy intake; CHO, carbohydrate; kJ/d, kilojoules per day; g/d, grams 
per day; E%, percentage daily energy intake. 





Figure 4.5 Estimated daily energy expenditure (mean ± SD) for commuter cyclists (n=13) 
determined by the average of 4-day food records at week 0 and weeks 4 and 8 with 






4.6 Body Composition 
Anthropometry 
Baseline data were similar between groups for percentage body fat (P = 0.28), sum of 
five skin folds (P = 0.37), waist circumference (P = 0.15), hip circumference (P = 0.71), 
WHR (P = 0.19) (Table 4.6a). Fasted body mass was greater (P = 0.01) in CYC than CON 
at baseline and a similar trend (P = 0.06) for BMI was observed (Table 4.2a). No effects 
of commuter cycling on body mass, sum of skin folds, percentage body fat, waist 
circumference or BMI were observed over time or between groups (Table 4.6a). Waist 
to hip ratio (WHR) decreased in CYC compared to CON (CYC -5.1 ± 5.8%, CON -0.2 ± 









































circumference with commuter cycling (CYC 5.3 ± 4.0%, CON 1.4 ± 3.1%, P = 0.01) 
(Table 4.6a). Waist circumference did not change (P = 0.36) (Table 4.6a). 
 
Dual energy x-ray absorptiometry (DXA) 
Commuter cycling had no effect (P > 0.05) on lean and fat mass determined by DXA.  
(Table 4.6b). Circumferences and ratio of waist and hip determined from the DXA were 
not observed to be altered (P > 0.05). 
 
Table 4.6a Body composition measures (mean ± SD) at baseline and after 10 weeks 
(Follow-up) by those commuter cycling (CYC) and a control group (CON). 
BMI, body mass index; WHR, waist-to-hip ratio. 
a P ≤ 0.05 ANOVA for the group difference in change from baseline to follow-up. 
 CYC (n=13)  CON (n=13)  
  Baseline Follow-up   Baseline Follow-up   P a 
Body mass 
(kg) 78.5 ± 9.0 





folds (mm)    76 ± 36 





(%) 30.2 ± 8.6 






















Table 4.6b Dual-energy X-ray absorptiometry measures of body 
composition (mean ± SD) at baseline and after 10 weeks of commuter 
























 WHR, waist-to-hip ratio. 




4.7 Cardiovascular Measures 
Maximum oxygen consumption 
Groups were similar (P = 0.71) in absolute V̇O2max (l ∙ min-1) and relative to body mass 
(ml ∙ kg ∙ min-1) (P = 0.45) at baseline (Table 4.2a). Absolute V̇O2max increased after 10 
weeks of commuting in CYC, however, in CON it decreased (CYC 10.4 ± 17.3 %, CON 
-1.5 ± 11.3 %, resp., P = 0.05) (Table 4.7a). A similar pattern was observed when 
calculated relative to body mass (CYC 10.5 ± 16.2 %, CON -2.8 ± 12.3 %, resp., P = 0.03) 
(Table 4.7a).  
Measure Baseline Follow-up  P a 
Total body fat (%) 129.42 ± 9.67 129.46 ± 9.82 0.93 
Total body lean (%) 166.55 ± 9.54 166.50 ± 9.71 0.90 
Waist fat (%) 137.06 ± 8.15 136.13 ± 8.51 0.92 
Hip fat (%) 136.62 ± 10.44 136.65 ± 11.10 0.92 
Hip lean (%) 163.36 ± 10.45 163.34 ± 11.08 0.95 
Trunk fat (%) 132.93 ± 8.50 133.28 ± 8.99 0.57 
Trunk lean (%) 167.07 ± 8.50 166.71 ± 8.99 0.57 
Legs fat (%) 131.10 ± 13.17 130.71 ± 13.11 0.34 
Legs lean (%) 168.89 ± 13.17 169.28 ± 13.11 0.34 
Arms fat (%) 125.99 ± 11.41 125.91 ± 11.21 0.82 
Arms lean (%) 174.01 ± 11.41 174.08 ± 11.21 0.82 
Hips (cm)   104.6 ± 8.8   103.8 ± 7.3 0.42 
Waist (cm) 1  88.1 ± 7.9 1  87.4 ± 8.5 0.31 
WHR   100.85 ± 0.09 100.84 ± 0.09 0.90 
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Table 4.7a Maximum oxygen consumption (mean ± SD) at baseline and at 10 weeks 
(follow-up) in commuter cyclists (CYC) and controls (CON). 
 CYC (n = 13)  CON (n = 13) 
 Baseline Follow-up  Baseline Follow-up 
Absolute V̇O2max    
(l ∙ min-1) a 
2.76 ± 0.8 2.97 ± 0.8  2.65 ± 0.7     2.6 ± 0.7 
Relative V̇O2max  
(ml ∙ kg ∙ min-1) b 
35.9 ± 8.2 38.7 ± 6.5  38.6 ± 9.9   37.2 ± 9.6 
a P = 0.05 ANOVA of the group difference in change from baseline to follow-up. 




Resting heart rate 
Groups were similar (P = 0.27) in resting heart rate at baseline. Resting heart rate 
decreased in CYC (-4.8 ± 6.2 %, P = 0.03) and increased in CON (2.6 ± 9.1 %) (Figure 
4.7a).  
 
Resting blood pressure 
Groups were similar at baseline for systolic (P = 0.18) and diastolic (P = 0.08) blood 
pressure. No effect (P = 0.20) of commuter cycling on systolic BP was detected (Figure 
4.7b). Diastolic BP decreased (P = 0.02) in CYC (-1.2 ± 7.3 %) and increased in CON 






Figure 4.7a Resting heart rate (mean ± SD) at baseline and at 10 weeks (follow-up) 
in commuter cyclists and controls (ANOVA for group change from baseline to 





Figure 4.7b Systolic (P = 0.20)a and diastolic (P = 0.02)a blood pressure (mean ± SD) 
at wk. 0 and at 10 weeks in commuter cyclists and controls. 































































One CYC participant was excluded from C-reactive protein (CRP) analysis due to 
elevated CRP levels that indicated an underling ailment (Haran, et al., 2013). No group 
differences were observed at baseline for total cholesterol (P = 0.66), HDL (P = 0.66), 
LDL (P = 0.29), triglycerides (P = 0.96), or CRP (P = 0.12). There were no significant 
effects of commuter cycling on any blood parameters (Table 4.7b).  
 
Table 4.7b Blood parameters (mmol/l plasma; mean ± SD) at baseline and at 10 weeks 
(follow-up) in commuter cyclists (CYC) and controls (CON). Analysis included 13 
participants per group, except where indicated otherwise. 
HDL, high-density lipoprotein; LDL, low-density lipoprotein.  
a P ≤ 0.05 ANOVA for the group difference in change from baseline to follow-up. 






 Baseline  Follow-up  
 CYC CON  CYC CON  P a 
Total  
Cholesterol  










3.24 ± 0.45 3.72 ± 1.03  3.20 ± 0.53 3.42 ± 0.97 
 
0.29 




Protein  b 





4.8 Quality of life 
Groups were similar at baseline for all health-related quality of life variables. No 
significant effects (P > 0.05) were observed after 10 weeks commuter cycling (Table 
4.8). However, a trend (P = 0.06) for social functioning to decrease was observed (CYC 




Table 4.8 Health-related quality of life parameters (mean ± SD) at baseline and after 10 
weeks (follow-up) commuter cycling (CYC) and a control group (CON). 






  Baseline  Follow-up   
  CYC CON  CYC CON  P a 
Physical functioning  96.2 ± 4.6 95.8 ± 5.7   96.9 ± 4.8 95.8 ± 4.0  0.67 
Role physical  94.2 ± 14.9 73.1 ± 42.7  90.4 ± 28.0 86.5 ± 24.2  0.54 
Bodily pain  84.6 ± 13.3 81.2 ± 13.9  80.3 ± 10.3 82.9 ± 16.7  0.72 
Mental health  80.3 ± 14.2 78.2 ± 10.4  78.8 ± 14.1 77.2 ± 9.9  0.52 
Role emotional  94.9 ± 18.5 79.5 ± 37.4  94.9 ± 8.5 76.9 ± 36.9  0.84 
Social functioning  92.3 ± 15.9 96.6 ± 5.3  88.0 ± 12.4 91.5 ± 12.1  0.06 
Vitality  61.9 ± 23.9 62.3 ± 13.9  65.0 ± 15.8 63.9 ± 14.2  0.32 
General health  73.3 ± 22.7 70.5 ± 12.1   76.8 ± 19.2 70.9 ± 11.4  0.29 
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4.9 Other Measures 
Glucose and insulin measures 
One CYC participant was excluded from glucose, insulin and homeostatic model 
assessment – insulin resistance (HOMA-IR) analyses due to uncertainty for the cause 
in the 81% lower plasma insulin level at follow-up than at baseline. The change in 
plasma insulin was not typical based on other eight to twelve week PA interventions 
(Yamamoto, et al., 2007, Gray, et al., 2009). Therefore error may have derived from 
participant compliance to fasting in the baseline measure or error during plasma 
analysis. Groups were similar at baseline for fasting plasma glucose (P = 0.85), insulin 
(P = 0.45) and HOMA-IR (P = 0.71). There were no significant effects of commuter 
cycling on glucose (P = 0.69), insulin (P = 0.61) or HOMA-IR (P = 0.61) (Table 4.9a).  
 
 
Table 4.9 Fasted plasma levels of glucose, insulin and HOMA-IR (mean ± SD) 
at baseline and after 10 weeks (follow-up) of commuter cycling (n=12) and 
control group (n=13). 
HOMA-IR, homeostatic model assessment – insulin resistance.  







 Baseline  Follow-up  
 CYC CON  CYC CON P a 
Glucose  
(mmol/L) 
5.41 ± 0.77 5.46 ± 0.54  5.25 ± 0.36 5.27 ± 0.47 0.69 
Insulin  
(uU/ml) 
6.79 ± 3.04 5.94 ± 2.43  7.00 ± 3.07 5.55 ± 2.91 0.61 
HOMA-IR  1.57 ± 0.71 1.47 ± 0.69  1.63 ± 0.76 1.33 ± 0.83 0.61 
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Cycling power output 
Groups were similar (P = 0.65) for peak power (w) output from the incremental V̇O2 
max cycling at baseline. Peak power improved (P < 0.001) in CYC (7.9 ± 11.7 %) 
whereas it decreased in CON (-9.8 ± 7.7 %) (Figure 4.9). 
  
Figure 4.9 Peak power output (mean ± SD) during incremental V̇O2 max test on cycle 
ergometer at baseline and after 10 weeks (follow-up) by those commuter cycling and a 







































CHAPTER 5: Discussion 
5.1 Overview 
The present study is the first to investigate the effect of introducing commuter cycling 
to an individual’s daily routine on existing physical activity and cardiovascular health 
and to compare this with a control group over the same time period. Following 10 
weeks of cycling totalling around 150 min/wk, cardiovascular fitness and resting heart 
rate were enhanced. Furthermore, an increase is diastolic blood pressure observed in 
the control group may have been thwarted amongst cyclists due the intervention. 
Unexpectedly, these health gains occurred despite the fact that there was no measurable 
change in the total amount of time engaged in physical activity. Perhaps even more 
surprising was the finding that parameters of cardiovascular health were improved 
without significant change in total body mass or proportion or distribution of fat mass 
and lean mass. Due to the relatively short time frame over which this trial was 
conducted, the possibility that if the commuter cycling was continued for a prolonged 
period, body composition changes may have occurred. Nevertheless, these data do 
support others demonstrating that physical fitness, health & longevity can be improved 
irrespective of body mass or composition (Lee, et al., 1999). The improvement in health 
without change in overall PA may have resulted from the increased energetic demands 




5.2 Physical activity  
Total physical activity  
Total PA, including commuter cycling and daily activities, as measured by logbooks 
was not observed to be altered. In the one other study that also examined the effect of 
a CC intervention on total PA, a greater total PA (inclusive of cycling) in cyclists than 
controls was observed (de Geus, et al., 2008). Although de Geus et al. (2008) observed 
greater PA in cyclists at the 26 and 52 week follow-up assessments, pre-intervention 
PA habits were not reported and therefore it is not known whether cyclists were 
already more active prior to the non-randomised group selection. Furthermore, de Geus 
et al. (2008) defined PA as leisure-time PA and cycling, which excludes PA from daily 
living (e.g. gardening, playing with children, occupation, etc.). In contrast, participants 
from our CC trial were instructed to report all types of PA, not just those from exercise.  
The lack of change in total PA with the addition of ~150 min/wk CC suggests that 
compensation in other physical activities occurred. Also in support of compensation in 
PA was the finding that energy intake (as determined by weighed food records) and 
body composition (DXA) were unaltered by cycling. The addition of CC without 
change to energy intake or change in body composition indicates energy expenditure 
(EE) was not significantly altered and was likely maintained at pre-intervention levels 
due to a decrease in PA outside of time spent cycling. However, despite the probable 
decrease in other activities, results showed no change in the recorded time engaged in 
PA outside of cycling. It may be that the method of capturing daily activities did not 
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have the resolution to identify changes in incidental, short lasting activities or that a 
shift of intensity of activities occurred. The increase in cardiorespiratory fitness in 
cyclists above that of controls favours the likelihood that short lasting, lower intensity 
activities were replaced with cycling at a greater intensity. Intensity of exercise 
generally has a greater effect than volume towards the adaptations that increase 
V̇O2max (Gutin, et al., 2002; Wenger & Bell, 1986; Thomas, et al., 1984).  
Although DXA measures of body composition support our conclusions that EE was 
unaltered by CC, it is important to acknowledge that estimating EE from food diaries 
has an unknown level of validity due to potential errors from self-reporting, which 
generally results in underestimated EE values (Jackson & Wootton, 1990). Furthermore, 
it is unknown if participants’ body mass was stable in the months prior to the 
intervention, which is another limitation of estimating EE from diet records.  
 
Moderate and vigorous physical activity 
Although total PA was unaltered by CC in the present study, time engaged in moderate 
and vigorous-intensity PA combined (MVPA) as reported in the International Physical 
Activity Questionnaire was greater at weeks four and eight than at baseline. The 
validity of IPAQ has been observed to be variable, ranging from low to high compared 
to objective PA measures (Lee, et al., 2011). Since objective measures of PA were not 
used in this study, the validity of IPAQ results is unknown. Nevertheless, with the 
removal of light intensity PA from daily logbook analyses, cyclists engaged in more 
MVPA than controls during the intervention period, even though groups were similar 
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(p > 0.05) at baseline, which supports the IPAQ results. The increase in MVPA with CC 
is corroborated by heart rate data. In conjunction with laboratory-based V̇O2max tests, 
heart rate data indicate that the intensity at which cycling was performed was 56 ± 11% 
V̇O2max, which corresponds to moderate-intensity PA. Therefore, CC increased the 
amount of time cyclists performed MVPA, but was insufficient to affect total PA and 
energy balance. The self-report instruments used to collect PA data may have 
contributed to the lack of observable changes (Vanhees, et al., 2010). Furthermore, the 
power analysis performed to determine the sample size for this study was not conducted 
on PA variables, and it is possible that this study is lacking in statistical power to draw 
firm conclusions about the role of CC on existing levels of PA. Still, the addition of 
commuter cycling has likely increased time engaged in MVPA, which is supported by 
our results for enhanced cardio respiratory function among cyclists.  
 
 
5.3 Cardiovascular health 
Maximal oxygen consumption  
The 10.5% increase in V̇O2max that we observed among commuter cyclists corroborates 
the findings of previous short term (i.e. 8-10 weeks) CC studies and demonstrates that 
the present study produced similar cardiovascular strain as previous investigations, 
which found a 7.3% (Oja, et al., 1991) and 12.5% (Møller, et al., 2011) increase in 
V̇O2max. Interestingly, our participants were, on average, younger (16%) and fitter 
(12%) than those from previous investigations, indicating that CC even has benefits for 
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young adults who lead active lives (Oja, et al., 1991; de Geus, et al., 2008; Møller, et al., 
2011).  Furthermore, V̇O2max is a robust predictor for cardiovascular health and 
morbidity (Haskell, et al., 2007). Therefore, findings from the present and previous 
studies indicate that cycling for transport, at a self-selected pace, can improve 
cardiovascular function in healthy adults in as little as 10 weeks. 
In their meta-analytic review, Kodema et al., (2009) performed a dose-response analysis 
to determine the role of fitness on risk of CVD events and mortality. The authors 
reported a 13% decrease in risk with each 1 MET (3.5ml/kg/min) increase in fitness 
from their analysis of 33 studies (Kodama, et al., 2009). The robustness of the evidenced 
presented by Kodema et al., (2009) for the role of fitness on CVD outcomes is not clear, 
and may be confounded by covariates that may influence the results. Nevertheless, the 
results from Kodama, et al., (2009) indicate a goal for the minimum amount of increase 
in fitness that should occur to see meaningful, long term benefits. In CC studies to date, 
only one group observed increases in fitness above 1 MET, but the authors omitted 
results on the volume or intensity of exercise performed by cyclists (Møller, et al., 
2011). We observed a 2.8ml/kg/min increase in V̇O2max with 150 mins/wk of 
moderate-intensity cycling and Oja, et al., (1991) observed a 3.1ml/kg/min increase 
with an estimated 210 min/wk of commuter cycling, also at moderate intensity. The 
increase in V̇O2max below 1 MET generally observed in CC trials may explain why 
prospective cohort studies have observed enhancements to CVD risk factors (i.e. fasting 
plasma glucose, triglycerides, systolic blood pressure) with habitual commuter cyclists, 
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but results haven’t been repeated in in short term CC trials (for reviews, see Hamer & 
Chida, 2008; and Oja, et al., 2011). 
Numerous adaptations occur with aerobic training that will increase V̇O2max. An 
increase in left ventricular mass results in an increase in end-diastolic volume, thus 
leading to improved stroke volume and cardiac output per heartbeat (Hickson, et al., 
1985). Although aerobic training, including cycling, is well established to increase 
ventricle mass, the exercise load from the present study was unlikely to have created 
enough strain to develop that adaptation in 10 weeks (Fagard, 1997; Hickson, et al., 
1985; Sipola, et al., 2009). Although skeletal, cardiac and enzymatic adaptations were 
not directly measured in this study, adaptations that are likely to have occurred with 
10 weeks of CC are increased mitochondrial density in skeletal muscle, quantity of 
oxidative enzymes and capillary density, which improves saturation and utilisation of 
oxygen at the muscle (Nadel, 1985; Andersen & Hendriksson, 1977; Klausen, et al., 
1981). A more prominent adaptation responsible for improved V̇O2max with CC is 
greater cardiac output through expanded blood volume, which increases the amount of 
circulating oxygen and thus allowing greater utilisation of oxygen at the muscle for 
aerobic metabolism (Gledhill, et al., 1999; Akgun, et al., 1974; Convertino, et al., 1991). 
If CC was performed long-term, further adaptations to cardiac muscle and vasculature 
may occur, further enhancing V̇O2max and may even reduce CVD risk factors that 
longitudinal studies have observed among commuter cyclists, but allusive in CC trials, 
such as the present study.  
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Blood pressure and resting heart rate 
A group difference in diastolic blood pressure was observed due to an increase in DBP 
among controls. Two other research groups monitored blood pressure and observed no 
change compared to controls after eight weeks (Møller, et al., 2011) and one year (de 
Geus, et al., 2008) of commuter cycling. In the present study, systolic blood pressure 
was not altered, which supports previous findings that CC is generally performed at an 
intensity and/or duration that is insufficient to strain the cardiovascular system enough 
to enhance BP. However, aforementioned authors observed a decrease in DBP amongst 
their participants who were commuter cycling, but they did not observe a significant 
group effect (Møller, et al., 2011; de Geus, et al., 2008).  The group effect for DBP 
observed in the present study should be approached with caution, as CC did not directly 
enhance DBP in cyclists. Nevertheless, this result is of importance because the time of 
year and location in which the study took place would likely have imposed seasonal 
fluctuations for time engaged in PA and consequent changes to health parameters. For 
example, we observed controls to have decreased cycling power output (10±7%), 
increased resting heart rate (3±9%), decreased V̇O2max (3±12%), and increased DBP 
(12±16%) at the end of the 10 week intervention period. The intervention period 
started in autumn and finished in winter and the study location was at latitude 45.8 
degrees south in which winter temperatures and daylight hours are less favourable for 
outdoor activities than regions further north. Seasonal influences on PA (Matthews, et 
al., 2001), risk of mortality from heart disease (Dunnigan, et al., 1970) and low levels of 
Vitamin D (Webb, et al., 1988) are well established. Low levels of Vitamin D3 contribute 
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to seasonal variation for blood pressure by working as a negative endocrine regulator 
on the renin-angiotensin system, which contributes to the regulation of blood pressure 
through reno-cardiovascular functions (Li, et al., 2002; Li, et al., 2004). In the present 
study, the seasonal increase in diastolic blood pressure observed in controls may have 
been prevented in cyclists and if this was the case, it was most likely through change 
of activity from the autonomic nervous system (Guyenet, 2006). 
Decrease of sympathetic tone, and to a lesser extent, an increase in parasympathetic 
tone is the probable mechanism for the prevention of seasonal DBP change (Tashiro, et 
al., 1993; Young, 2010). The decrease in sympathetic tone reduces activity of arterial 
smooth muscle causing endothelium vasodilation and thus reduces systemic vascular 
resistance (Guyenet, 2006; Young, 2010). The reduction in vascular resistance is the 
primary mechanism for decreased arterial blood pressure at rest with regular exercise 
(DeSouza, et al., 2000; Tashiro, et al., 1993).  
A change to the autonomic nervous system at rest is also most likely the primary 
mechanism for the reduced resting heart rate that we observed after 10 weeks of CC 
(Ekblem, et al., 1973). Reduced sympathetic activity alters the contractility of the 
cardiac muscle at rest through reduced tone of adrenergic cardiac nerves to the atria 
and ventricles to lower norepinephrine secretion, as well as on the adrenal medulla and 
consequent reduction of circulating epinephrine and norepinephrine (Young, 2010). 
The finer control of cardiac muscle contractions, combined with the increased stroke 
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volume that likely occurred from an expanded plasma volume with CC, would result 
in fewer heart beats per minute to maintain resting cardiac output. 
Evidence of the relationship between morbidity and blood pressure is robust (He & 
Whelton, 1999; Cook, et al., 1995). Similarly, resting heart rate is an indirect measure 
of vascular resistance as it relates to stroke volume and resting cardiac output, all of 
which are indicators of cardiovascular function and independently linked to risk of 
mortality by cardiovascular disease (Fox, et al., 2007; Diaz, et al., 2005; Jouven, et al., 
2005). Adaptations required to improve blood pressure and heart rate at rest are well 
established with exercise training (For review, see Arroll & Beaglehole, 1992; Chen & 
Dicarlo, 2009). The present study is the first to observe that the introduction of 
commuter cycling to an individual’s daily routine improves these variables above that 
of controls. It is important to note, however, that this is the only known controlled 
study to monitor resting heart rate with novel commuter cycling and, therefore, these 
results require confirmation. 
 
5.4 Energy expenditure and body composition 
Energy expenditure 
Energy expenditure of CC, as estimated by heart rate while commuting and V̇O2 data 
from a lab-based sub-maximal cycling test, was approximately 5600 kJ/wk. The addition 
that cycling had on EE did not alter DXA measures of lean or fat mass in cyclists’ 
appendages, trunk or whole body. An absence of change to body composition and 
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energy intake despite an increase in EE further supports our suggestion that a decrease 
in non-cycling PA took place during the cycling intervention. How EE is affected long-
term by introduction of a new PA habit (e.g. commuter cycling) has not been 
thoroughly investigated in healthy adults, and in general is under reported in physical 
activity interventions, particularly those using a free-living population (i.e. activity 
behaviour unmanipulated by participation in research) (Garland, et al., 2010). Wickel 
and Eisenmann (2006) are the authors of the only known study that has investigated 
compensation of EE in healthy adults. They reported that EE (assessed using the gold-
standard, doubly-labelled water technique) from light-intensity activities to change 
inversely with the amount of moderate and vigorous PA performed by participants. In 
support of this, a meta-analytic review reported that within-individual variation of 
daily EE is relatively stable and low at 13% in a free-living population (Black & Cole, 
2010). Therefore EE from MVPA may increase total EE, but only up to a point (i.e. 
13%) before compensatory mechanisms limit further changes to total daily EE.  
The role of exercise-induced EE on improved health parameters is widely accepted. 
However, the present study resulted in improvements to major cardiovascular markers 
of health without change to total EE through a compensation of light-intensity 
activities. The mechanisms involved in the regulation of EE are complex, involving 
hormones, circulating and stored substrates, feedback from peripheral tissues and 
substrate utilisation to higher centres (For review, see King et al, 2006; Garland, et al., 
2010). The role of compensation of EE and the effects it has on cardiovascular gains 
from novel exercise warrants further investigation. 
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Body composition  
Ten weeks of commuter cycling for 150 min/wk at moderate intensity (56 ± 11% 
V̇O2max) had no effect on adiposity in the present study. Møller et al. (2011) also 
investigated body composition change with novel commuter cycling. They reported 
that skin fold thickness decreased after eight weeks and more so in the cycling group 
than controls. Study characteristics were similar between the present study and that of 
Møller et al. (2011). Both utilised a randomised control group, included males and 
females who had similar body mass, BMI, and V̇O2max. The only difference was that 
participants in Møller et al. (2011) were on average five years older. Møller et al. (2011) 
estimated 40 min of daily cycling (200 min/wk) was performed, which is 25% greater 
than cyclists from the present study. However, authors did not report the volume of 
cycling performed, but in the present study, participants averaged 5624 ± 1776 kJ of 
weekly cycling, based from sub-maximal V̇O2 testing and heart rate responses to 
cycling, which was insufficient to alter adiposity in normal-weight adults after ten 
weeks. 
In contrast to DXA measures, manual measures of waist-to-hip ratio (WHR) decreased 
with CC at follow up, due to an increase in hip circumference in cyclists. WHR was 
similar (i.e. P = 0.78) between manual measures and DXA, indicating validity between 
the two measures at pre-intervention testing. However, circumference measures 
differed between instruments. The difference in waist measurements from manual 
measures and DXA remained consistent before (~4.8 cm) and after the intervention 
(~4.2 cm). However, the difference in hip circumference before (~6.3 cm) and after 
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(~0.5 cm) the intervention was significant (p < 0.05). Unaltered DXA measures of lean 
and fat mass in the hip region combined with inconsistencies in manual hip 
circumference measures indicate that the measures contain errors, which produced a 




5.5 Blood parameters 
Blood cholesterol 
We observed no effect of 10 weeks of CC on triglycerides and cholesterol, which agrees 
with findings from Oja et al. (1991) who also observed no change in high-density 
lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol as well as 
triglycerides in their 10 week commuter cycling intervention. Commuter cycling for 
26 and 52 weeks also appears to be insufficient to improve triglycerides and cholesterol 
fractions (de Geus, et al., 2008). A lower threshold exists for improvement to HDL with 
exercise training than LDL cholesterol (Mann, et al., 2014). Some evidence indicates a 
minimum amount of EE is required from PA to improve HDL and 4600 kJ/wk has been 
suggested as the lower threshold for improvement (Ferguson, et al., 1998; Mann, et al., 
2014; Harrison, et al., 2012). Although we could not identify compensatory behaviours 
with CC, it is likely that some form of activity compensation reduced the impact of CC 
on total EE and thus HDL was unaltered from 10 weeks of CC. Furthermore, regular 
PA has been shown to increase lecithin cholesterol acyltrans enzyme, which promotes 
the transfer of cholesteryl ester to HDL and consequent removal of LDL through the 
liver (Riedl, et al., 2010; Calabresi & Franceschini, 2010). Without increased HDL from 
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CC, adaptations that reduce LDL were unlikely to have occurred. Even if the CC was 
continued over a longer period of time it is unclear if LDL would have improved, as 
changes to LDL with aerobic exercise with longer trials (e.g. 26+ weeks) is supported 
by some (Grandjean, et al., 1996; Tikkanen, et al., 1999; Dunn, et al., 1999), but not 
others (Wing, et al., 1998; de Geus, et al., 2008; Hersey, et al., 1994). Conflicting results 
are likely due to differences in health and fitness of participants at the onset of 
intervention between studies (Tambalis, et al., 2009). Furthermore, reduced LDL 
cholesterol is more responsive when accompanied with altered diet (Jenkins, et al., 
2011; Kelley, et al., 2012) or with training at high-intensity (e.g. > 60% of V̇O2max) 
(Ponjee, et al., 1995; Lindheim, et al., 1994; Tikkanen, et al., 1999). Neither scenario 
was observed in the present study, but LDL cholesterol was included as an outcome 
measure because de Geus et al (2007) observed commuters cycling at high-intensity (i.e. 
75% V̇O2max) in their study. But we observed commuter cyclists to generally cycle at 
moderate intensity, which was insufficient to alter cholesterol levels in 10 weeks. 
 
Glucose and insulin  
Commuter cycling did not alter blood levels of glucose and insulin after 10 weeks. To 
ensure our results were not affected by any acute effects, fasting blood samples were 
obtained between two and seven days after post-intervention V̇O2max testing. Energy 
expenditure directly enhances insulin and glucose dynamics up to 24 hours from a 
single bout of exercise, whereas exercise training may offer sustained effects up to seven 
days of detraining (Devlin & Horton, 1985; Mann, et al., 2014). Others have used a 
102 
 
similar exercise load and duration to the present study and observed enhanced glucose 
regulation (Mourier, et al., 1997; Raz, et al., 1994). However, those studies included 
participant groups who had impaired glucose management. The present study used a 
younger group of adults (39 ± 7 years) without impaired blood glucose management. 
Data on changes to glucose and insulin dynamics with PA in non-elderly and non-obese 
adults with normal fasting blood glucose are surprisingly sparse (Sénéchal, et al., 2014). 
Participants from our study had low values of fasted blood glucose and therefore only 
small changes are likely to occur to glucose and insulin levels, which may be more 
difficult to detect.   
Comparatively few data exist for contextualising our results; however the lack of 
observable change to EE has likely contributed to the absence of improvements to 
fasting glucose and insulin. Energy expenditure from moderate-intensity cycling 
among active and non-obese men has previously enhanced blood glucose management 
with 3760 kJ/wk, in which authors proposed as the minimum threshold to improve 
insulin sensitivity in that population (Magkos, et al., 2008). In support of findings from 
Magkos et al. (2008), insulin sensitivity was unaltered with exercise training that was 
below 3760 kJ/wk (Kang, et al., 1996; Cusi, et al., 2000). Evidence for the importance 
of intensity versus total EE on glucose management is unclear. Whether an increase in 
the intensity of activities without change to EE has the same or greater effect than total 





C-reactive Protein  
C-reactive protein (CRP) was unaltered by 10 weeks CC. Others also observed 
commuter cycling to have no effect on CRP at weeks 26 and 52 (de Geus, et al., 2008). 
It is possible that the intensity of commuter cycling is not high enough to alter CRP, 
which has been suggested to respond best to high-intensity training, but more evidence 
on the role of intensity for this leading biochemical predictor for CVD is required 
(Plaisance & Grandjean, 2006; Chen, et al., 2014). Further obscuring change to CRP 
was the high prevalence of self-reported illness amongst cyclists towards the end of our 
CC intervention (figure 4.1c). Illnesses such as the common cold or any injury which 
results in an inflammatory response increases CRP, which may be responsible for the 
unexpected, but non-significant 34% mean increase we observed in CRP with CC 
(Haran, et al., 2013).  
 
5.6 Health-related quality of life 
Health-related quality of life (QOL) was not enhanced with CC; moreover, a trend for 
decreased social functioning was observed. Mean scores for social functioning were 
lower in both groups after the intervention and therefore were likely to have been 
caused by factors unrelated to the intervention per se, but rather to environmental 
factors (e.g. season, day length, weather). Utilising the same Short-Form 36 QOL 
questionnaire, de Geus et al. (2008) also observed changes in both participant groups, 
with enhanced role-physical and vitality reported in cyclists and controls after a 52 
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week CC intervention. The physical activity performed in our study, as well as that of 
de Geus et al., (2008), may have a lesser influence on QOL than factors outside of the 
intervention, evidenced by the changes in both participant groups in each study. 
As previously mentioned the present study started in autumn and finished in winter, 
whereas participants from de Geus et al (2008) were tested in spring after CC in winter. 
Seasonal changes to QOL are well documented, with winter conditions worsening QOL 
measures (Lubetkin & Jia, 2009). Therefore a lack of improvements from CC in the 
present study, but enhancement is some QOL measures by de Geus et al. (2008) may be 
explained, in part, with timing of testing sessions in relation to the seasons. 
Differentiating the effect of QOL from seasonal changes and those from commuter 
cycling cannot be determined with current available evidence. Furthermore 
conclusions are further hindered by the scale of QOL instruments that are not purpose 
designed for young and healthy populations.  
 
5.7 Conclusions 
Commuter cycling (~150 min/wk) improves indices of cardiovascular health. These 
improvements in cardiovascular health occurred without measurable changes in overall 
physical activity, energy intake, estimated energy expenditure or body composition. It 
appears that more intensive commuter cycling replaced other lower intensity activities 
that were below the resolution of our instruments to quantify. Blood parameters were 
unaltered, but as a weekly minimum increase in EE of 4600 and 37600 kJ/wk are 
recommended to improve HDL cholesterol and blood glucose handling, respectively, it 
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may be that the estimated EE from cycling of 5600 kJ/wk was insufficient to alter total 
EE, or that the duration was too short to elicit these changes. It is also possible that 
compensation of EE may have reduced the metabolic strain that is necessary to 
substantially alter these parameters. Few data exist on the impact of adding a novel 
form of physical activity on other pre-existing physical activities (i.e. compensation) in 
healthy adults. Typically, research participants are asked to not alter anything else in 
their daily regimen. Although it appears that some compensation did occur in our 
intervention, this did not pre-empt the increase in cardiovascular fitness. Based on our 
findings it appears that self-paced, moderate-intensity commuter cycling can improve 
cardiovascular health without changes in energy balance or body mass or composition. 
Thus, one may conclude, that at an individual level, focussing on BMI or body mass 
may be counterproductive when attempting to encourage and assess the benefits of 







CHAPTER 6: Conclusions 
Many people are not achieving public health recommendations for the amount of 
physical activity known to reduce risk for disease. A major barrier to increased 
participation of physical activity is the amount of free time perceived to be available 
(Sallisa, et al., 2015). Physically active modes of transport can support the accumulation 
of physical activity in a time efficient manner by incorporating physical activity in the 
time of day that would otherwise be used to travel. Additionally, government and 
health agencies are promoting use of physically active forms of transportation to 
improve health, reduce traffic congestion and pollution.   
Our study adds clarity to existing knowledge of commuter cycling. We observed 
commuter cycling to enhance major markers of cardiovascular health in just 10 weeks, 
which offers health promotors evidence that cycling to work will have personal health 
benefits. Furthermore, an increase in energy expenditure is not necessary to reduce 
markers associated with risk of cardiovascular disease. However, our study has 
highlighted an under-reported issue in physical activity research, that adding novel 
daily PA may not increase total physical activity or energy expenditure in healthy 
adults. The extent that metabolic and cardiovascular strain was reduced due to the lack 
of increase in energy expenditure is unclear. Nevertheless, it is encouraging that other 
markers of cardiovascular health such as V̇O2max and resting heart rate can improve, 
despite the small contribution cycle commuting made to participants’ physical activity 
levels. In addition to these positive findings, the duration of time and physiological 
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intensity that people are willing to spend cycling to and from work has now been 
defined in a New Zealand context.  
Results from the present study demonstrate that commuter cycling at moderate 
intensity for ~150 min/wk for ten weeks is not sufficient to improve body composition, 
health-related quality of life or select blood parameters (i.e. cholesterol, fasting insulin 
and glucose, C-reactive protein, or triglycerides) in healthy, normal weight adults. It is 
unknown if a greater amount of physical activity and energy expenditure, negative 
energy balance or duration of intervention is necessary to affect these parameters in 
this population.    
 
Prospective research direction 
Measuring the health gains acquired from novel commuter cycling is challenging for 
researchers. Short term trials lessen the opportunity for mechanisms to take place that 
enhance health, whereas longer trials report lower compliance, particularly through 
winter months. Further confounding our understanding of commuter cycling is that 
individuals who are likely to choose cycling as a means of transport over the 
conveniences of an automobile tend to be young or middle-aged adults who are already 
physically active (Damant-Sirois & El-Geneidy, 2015; Wanner, et al., 2012). Habitually 
active people generally have improved markers of cardiovascular health than their 
sedentary peers and have less to gain with novel PA. We therefore suggest that future 
research focus on defining the frequency, intensity and duration of cycling performed 
by habitual commuter cyclists. Furthermore, the load of commuter cycling should be 
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contextualised in rural verses urban environments and geographical location as it 
relates to weather and typography. If generalisations about the load of PA performed 
with commuter cycling can be defined, potential health benefits can then be 
extrapolated based on findings from numerous existing data on the effects of aerobic 
cycling on health.  
 
Summary 
Our results indicate that commuter cycling at a self-selected intensity is sufficient to 
enhance aerobic fitness, resting heart rate and prevent seasonal increases in diastolic 
blood pressure, which are all predictors of cardiovascular health. The addition of 
commuter cycling may result in a reduction in other forms of PA, although this doesn’t 
preclude all its health benefits. Noteworthy is that enhancement in cardiovascular 
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Participant ID ___________ (office use only) 
 
Name:      Date: 
 
The purpose of this questionnaire is to assess the types of physical activities you perform 
and the amount of time you spend performing each activity. 
 
Please answer each question as completely as possible and feel free to use the bottom of 
the sheet if you need more space to write. If you have any questions, please ask James at 
novbr02p@otago.co.nz  or 021-067-0519.  
 
Occupational activities:  
 
1. What is your occupation?  
 
 
2. Which suburb do you work in?  
 
 
3.How do you currently travel to work? (e.g. car, bus, walk, bike, etc) 
 
Type of transport  Duration (each way) Frequency (times per 
week) 
Example: bus, then walk 
 
12min (bus) & 5min (walk) 10 
 
   
   
 
4. How many minutes/hours a day do you spend standing while at work (approximately)? 
 
 
5. How many days a week do you work? 
 
 
6. Please list any physical activities you frequently perform while at work: 
    For example:  walking, heavy lifting, talking the stairs, etc. 
Activity Duration (minutes) Frequency (times per 
week) 
   
   
   





1. Have you competed in any sport competitions in the last 3 months? If yes, please 




2. have you trained or intend to train for a competition in the previous or next 3 months? 
 
 
3. Please list any recreational activities you frequently perform: 





















Activity Duration (minutes) Frequency (times per week 
or month) 
   
   
   
   
   
   
xviii 
 





1. Please list any recurring physical activities you perform around your home: 
For example, mowing the lawns, gardening, walking the dog, playing with your children,  
Activity Duration (minutes) Frequency (times per 
week) 
   
   
   
   











Figure 4.4c Time spent in total physical activity (mean ± SD) at week 0 and 
average of weeks 1-10 in cycling (n=13) and control (n=12) groups (one-way 
ANOVA for difference from baseline P = 0.24). 
 
 
Figure 4.4d Time spent in vigorous and moderate intensity physical activities 
combined (mean ± SD) at week 0 and average of weeks 1 – 10 in cycling (n=13) and 


































































































Figure 4.4f Time spent in total physical activity (mean ± SD) outside of commuter 
cycling, at week 0 and average of weeks 1 through 10 in cycling and control groups (one-




Figure 4.4h Time spent in vigorous and moderate physical activity (mean ± SD) outside of 
commuter cycling, at week 0 and average of weeks 1 through 10 in cycling and control 
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